LLSAR2004 pgs 1-16

2005 Annual Report

LEUKEMIA

LYMPHOMA

MYELOMA

Over its history, the Society has been the recognized leader in the ﬁght

against leukemia. Our name change to The Leukemia & Lymphoma

Society in 2000 was simply perception catching up to reality. The

Society’s objective is to ﬁnd cures for all blood cancers, and to be

the leading resource for patients battling all of these cancers.

This year, the Society took the ﬁrst step in making access to speciﬁc

information and services simpler for patients with these cancers.

We developed a color-coding system for the three main categories

of blood cancers: Our new signature colors are green for leukemia,

gold for lymphoma and blue for myeloma. Any information that

is relevant to all the diseases is coded burgundy. All print materials

prepared for patients during this year reﬂect the new system,

making access to important information and resources more efﬁcient.

You’ll also see our new colors in such e-newsletters as LeukemiaLinks,

LymphomaLinks and MyelomaLinks.

The next step will be to extend the new system to other venues,

including access to information on the Society’s Web site.

This year’s Annual Report displays the new colors with pride. They

represent the ongoing efforts to constantly improve on the ways

the Society serves and supports patients and those who love and

care for them.

2005 | ANNUAL REPORT

Cure leukemia,

lymphoma,

Hodgkin’s

disease and

myeloma, and

improve the

quality of life

of patients and

their families.

our mission

2 3

2005 | ANNUAL REPORT

We are fortunate to be able to report that ﬁscal year 2005 was a banner year for

the Society in many ways. Let’s start with revenue. The Society raised $218.6 million

through private donations, corporate gifts and our various fundraising campaigns – that’s

$38 million more than we raised in ﬁscal 2004. Our already successful campaigns such

as Team In Training

and Light The Night

Walk were even more productive in ﬁscal

2005 (for information on individual campaigns, please turn to pages 12 and 13 of this

report). And our donor development initiatives have shown impressive growth – a

38 percent increase in revenue over last year, to more than $25 million in ﬁscal 2005.

The big story of the year is not just our success as fundraisers, but also our success as

prudent stewards. Since its founding in 1949, the Society has been steadfast in pursuing

its mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve

the quality of life of patients and their families. In ﬁscal 2005, we were able to strengthen

our commitment, supporting four new Specialized Center of Research (SCOR) grants

and renewing two others – for a total of six SCORs awarded in the ﬁscal year, a Society

record. More money for the best research globally means more research successes; and

more research successes mean greater hope for the hundreds of thousands of patients

battling leukemia, lymphoma and myeloma.

Finally, The Leukemia & Lymphoma Society of Canada became part of the Society

effective July 1, 2004, and this year’s annual report is the ﬁrst to include our Canadian

operations. We are pleased to be serving the needs of patients and families in Canada

as well as in the United States.

Until the day comes when we can ﬁnally say we’ve defeated blood cancers, the Society

will be here to help guide patients and their families on the cancer journey. In ﬁscal year

2005, the Society had 2.5 million contacts with patients, caregivers and healthcare

professionals, through our Web site, Information Resource Center, education programs

and chapter-based outreach.

Yes, we made great progress in advancing our mission in ﬁscal 2005, thanks to the

dedicated volunteers, employees, donors and researchers who helped make the year

so successful. We are looking forward to doing even more in ﬁscal 2006!

Dwayne Howell

President & CEO

John M. Kamins

Chairman

leadership

message

2005 leukemia

highlights

patient services

In 2005, the Society offered new educational and support

programs and services to meet the needs of patients

battling AML, CML, ALL and CLL.

A small sample of new Society programs, services and

materials follows:

■

New Approaches to CLL: The Changing Treatment

Landscape,

featured world-renowned hematologist/

oncologist Michael Keating, M.D., The University

of Texas M.D. Anderson Cancer Center. A better

understanding of how leukemia cells work and grow

has led to targeted therapies for individual patients,

and more reﬁned diagnostic tests have enabled doctors

to devise smarter treatment strategies for all patients.

In this program, Dr. Keating discussed the latest news

about CLL, as well as clinical trials that might lead

to even better treatments in the future.

■

Medical Update on AML: New Treatments and Blood

Stem Cell Transplantation,

was jointly presented by the

Society, the National Bone Marrow Donor Program and

Cancer

Care. The program featured Selina Luger, M.D.,

University of Pennsylvania Cancer Center, who presented

an overview of AML; and J. Douglas Rizzo, M.D., Medical

College of Wisconsin, who discussed treatment options,

including marrow and blood stem cell transplantation.

■

CML: Ask the Expert, a telephone education program,

featured Stephen D. Nimer, M.D., head of the Division

of Hematologic-Oncology, Memorial Sloan-Kettering

Cancer Center. The entire one-hour session was devoted

to Dr. Nimer ﬁelding questions from the audience,

a format of great value to participants.

■

New Discoveries in CML: This teleconference featured

two distinguished experts from M.D. Anderson: Francis J.

Giles, M.B., M.D., F.R.C.P.I., F.R.C.Path, professor of

medicine, Department of Leukemia; and Moshe Talpaz,

M.D., professor of medicine, Department of Experimental

Therapeutics. They discussed the latest information

on CML therapies and the future direction of CML

research, and they answered questions from the

audience about CML clinical trials, newer treatments

and other topics of interest.

■

An updated booklet, Acute Lymphocytic Leukemia,

provides information on this cancer, current treatments,

new research directions and emotional aspects

of managing the disease.

2005 | ANNUAL REPORT

research

In the ﬁght against blood cancers, leukemia research

has arguably led the way, with major innovations in

the development and testing of targeted therapies

in just the past ﬁve years. Gleevec

, the ﬁrst product

of this research, was only the beginning. This Society-

funded breakthrough has led to additional studies that

are further advancing treatment options for patients with

chronic myelogenous leukemia (CML) and for those

battling acute myelogenous leukemia (AML) and acute

and chronic lymphocytic leukemia (ALL and CLL).

They include:

■

The Society funded a new Specialized Center of

Research (SCOR) grant,

Targeted Inhibition of

Oligomeric Translocation Products in AML, CML and

ALL,

led by John Bushweller, Ph.D., the University of

Virginia. The ﬁve-year project will focus on new

therapies for Gleevec-resistant CML patients and

AML and ALL patients who do not respond to

standard therapies. This SCOR expands on current

knowledge about the speciﬁc genetic defects that

create malignancies in blood cells that harbor them,

and on the successful application of Gleevec to

many patients with CML.

■

Charles Sawyers, M.D., UCLA School of Medicine,

presented ﬁndings at the 46th Annual Meeting

of the American Society of Hematology (ASH) for

a new agent, BMS-354825. In clinical trials of this

agent, 86 percent of early-stage CML patients resistant

to Gleevec experienced a complete hematological

remission. Dr. Sawyers, a SCOR team leader, credited

earlier Society-funded research on Gleevec resistance

with his ability to move ahead with recent, highly

successful clinical trials.

■

Varsha Gandhi, Ph.D., The University of Texas M.D.

Anderson Cancer Center, received a Translational

Research Program (TRP) grant from the Society

for her work,

DNA Independent Strategy to Target

CLL.

Many types of leukemia are caused by increased

cell proliferation and are frequently treated with drugs

that target DNA. In contrast, CLL expansion is more

often associated with decreases in leukemic cell death.

Dr. Gandhi’s research focuses on a chemotherapeutic

agent called chlorinated adenosine (8-CI-Ado),

which has been shown to cause CLL cell death in

laboratory models by decreasing energy stores and

the production of new RNAs, both critical to cell

survival. Dr. Gandhi will now study what happens

when 8-CI-Ado is introduced into fresh peripheral,

(circulatory) blood cells obtained from patients

with CLL. The objective is to advance this agent

to clinical trials.

“

”

hunter’s story

On the Friday afternoon when the doctor

announced that our 10-month-old son had

leukemia, I was very frightened even though

I wasn’t 100 percent sure what leukemia was.

It was a great reassurance when, by Monday

afternoon, the Society had contacted our home

and was helping us cope with the diagnosis. They

followed up regularly and continued to supply

information as my son’s situation changed.

• Lori Ruderman, mother of 6-year-old Hunter,

leukemia survivor.

“

”

We’re currently testing a new agent,

BMS-354825, in clinical trials among

CML patients resistant to Gleevec, and it shows

tremendous promise for getting patients

into complete hematological remission.

Earlier Society-funded research

we did on Gleevec resistance

enabled us to get to this point.

Charles Sawyers, M.D., UCLA School of Medicine

6 7

2005 | ANNUAL REPORT

2005 lymphoma

highlights

research

Below are just three examples of outstanding

Society-sponsored lymphoma research, including

laboratory studies, clinical trials and a collaborative

Specialized Center of Research (SCOR) project, all of

which will help advance the search for cures.

■

A SCOR grant was awarded to Tak Mak, Ph.D.,

Advanced Medical Discovery Institute, University

of Toronto, for a ﬁve-year project,

Signaling

Pathways in Lymphoma and Leukemogenesis.

These collaborative studies will increase our

understanding of lymphoma and leukemia

processes and direct the development of new

anti-cancer agents and clinical trials. Dr. Mak

and his team will identify how genetic defects

in blood stem cells cause the formation of rare

cancer stem cells that expand to form lymphomas

and leukemias.

■

A Translational Research Program (TRP) grant to

Alain Rook, M.D., University of Pennsylvania, was

renewed this year for his ongoing investigation into

promising new therapies for patients with T-cell

malignancies. Dr. Rook and his team discovered

that immune system cells in patients with

extensive cutaneous T-cell lymphoma (CTCL) were

typically not producing a molecule called CD40L,

rendering them unable to attack and kill

lymphoma cells. In the laboratory, synthetic CD40L

markedly improved immune cell anti-lymphoma

activity. Dr. Rook’s new study,

CD40 Ligand Defect

in Cutaneous T-Cell Lymphoma,

will investigate

the cellular and molecular reasons for the

CD40L effect with a goal of administering the

new drug in clinical trials to treat patients with

advanced CTCL.

■

Weiguo Zhang, Ph.D., Duke University Medical

Center, received a Career Development Program

(CDP) grant for a study titled

Adaptor Proteins

in Lymphocyte Activation.

The research studies two

molecules, LAT and LAB, found in certain immune

cell (lymphocyte) membranes. These molecules

were shown in previous studies to be essential

for the lymphocyte activation and development

that is needed for effective immune responses

patient services

A number of new educational and support programs

were developed this year to answer the needs of

patients battling Hodgkin and non-Hodgkin lymphoma.

A small sample of new programs follows:

■

Information for the Newly Diagnosed: A Patient’s

Guide

is part of our ongoing program, Insights

Into NHL,

a year-long series of teleconferences

and newsletters for non-Hodgkin lymphoma (NHL)

patients and families. This telephone education

program featured Andrew Zelenetz, M.D., chief,

Lymphoma Service, Memorial Sloan-Kettering

Cancer Center. Dr. Zelenetz explained the importance

of diagnosing the sub-type of lymphoma and

determining its location(s) in the body, stage of

development and other factors to ensure the best

treatment. Clinical trials also were discussed, and

Dr. Zelenetz answered questions from the audience.

■

Meet the Expert on Non-Hodgkin Lymphoma was

updated this year and offered at chapters across

the nation to share new information on NHL with

patients at the community level. This informative

program featured local lymphoma experts and

cancer-care professionals.

■

Emerging Therapies for Orphan Lymphomas:

Cutaneous T-Cell, Peripheral T-Cell, Mantle Cell,

Mucosa-Associated Lymphoid Tissue (MALT) and

Waldenström’s Macroglobulinemia,

a teleconference,

featured Francine Foss, M.D., Ph.D., F.A.C.P., associate

professor of medicine, director, Lymphoma Service,

Tufts New England Medical Center; David J. Inwards,

M.D., assistant professor of medicine, practice chair,

Hematology, Mayo Clinic College of Medicine; and

Morie A. Gertz, M.D., professor of medicine, division

chair, Hematology, Mayo Clinic College of Medicine.

These “orphan” lymphomas (meaning that they affect

fewer people than the more common types of this

cancer) were explained along with the latest treatment

advances and clinical trials.

against tumor cells. Ongoing studies in mice

will determine how these proteins function

in the immune system. Results will likely help

in the development of a new class of molecularly

targeted drugs for patients with lymphoma

and leukemia.

“

”

vaithee’s story

The Society has helped us in so many ways —

from ﬁnancial support for expenses not covered

by health insurance to tickets to baseball games

to keep our spirits up. Through the First Connection

program I was able to talk to someone who is

living healthy and cancer free. That was a great

morale booster in a dark time.

• Subramanian “Vaithee” Vaitheeswaran,

non-Hodgkin lymphoma survivor.

”

“

Thanks to our Society SCOR grant,

we’re able to develop customized

lymphoma vaccines that we hope will trigger

an immune response speciﬁcally

against an individual’s tumor.

This will make the ﬁrst treatment

the best treatment for that patient.

Ronald Levy, M.D., Stanford University School of Medicine

2005 | ANNUAL REPORT

2005 myeloma

highlights

research

Three new, Society-funded research programs are

examples of current efforts in the search for improved

therapies and cures.

■

A Translational Research Program (TRP) grant was

renewed this year for David Avigan, M.D., Beth Israel

Deaconess Medical Center. In previous studies, whole

myeloma tumor cells and normal immune cells, both

taken from a patient, were fused, and these fused

cells were used to stimulate (immune) T cells to

recognize and kill myeloma cells from the same

patient. In his new study,

Vaccination with Dendritic

Cell Tumor Fusions in Conjunction with Stem Cell

Transplantation as a Novel Immunotherapy for

Multiple Myeloma,

Dr. Avigan will conduct clinical trials

in which stem cell transplant patients with myeloma

will be immunized with a customized fusion vaccine

to determine whether these vaccines will improve

chances for patient survival.

■

Lawrence Lum, M.D., Roger Williams Medical

Center, received a TRP grant for a project called

Circumventing Rituximab Resistance in Patients with

B Cell Malignancies.

Dr. Lum will study the effects

of a molecule he created, CD20Bi, on myeloma and

lymphoma cells. The molecule links a drug used to

ﬁght these cancers, rituximab, with a patient’s own

T cells. Dr. Lum’s new research will determine whether

patients who are resistant to rituximab can beneﬁt

from multiple infusions of their own rituximab-armed

immune cells, following chemotherapy and stem

cell transplantation. If successful, this clinical study

will improve survival and decrease relapse rates

for myeloma and lymphoma patients.

patient services

The Society provided several new myeloma

resources this year. These are just a few of the

Society’s programs and services for myeloma

patients, their families and caregivers:

■

The Latest News About Myeloma featured

renowned hematologist Seema Singhal, M.D.,

director, Multiple Myeloma Program, Northwestern

University Medical School/Robert H. Lurie

Comprehensive Cancer Center. She shared her

optimism about the future of treatment for this

cancer and provided updates on new therapies

and combination treatments, clinical trials, genetic

testing and other factors that are dramatically

changing the landscape for myeloma patients.

■

Exploring Myeloma was launched to provide

patients with a new educational resource. Led

by local blood cancer experts,

Exploring Myeloma

presents a thorough overview of the cancer in

an easy-to-follow, one session, classroom format.

The program, piloted this year in seven Society

chapters, includes a one-hour slide presentation,

followed by an hour-long Q&A with the experts.

Exploring Myeloma also examines the emotional

and social aspects of a myeloma diagnosis.

It is being offered at all Society chapters in 2006.

■

Two new educational booklets were created

this year:

Myeloma provides a comprehensive

overview of the cancer, with segments on the

disease, how it’s detected, treatment options

and what the future for this disease may hold,

based on today’s research. Social and emotional

aspects are also explored.

Myeloma: A Guide

for Patients and their Families

gives information

on how to help manage this cancer from diagnosis

through treatment.

■

Jing Chen, Ph.D., Emory University, received a

Career Development Program grant for

Molecular

Therapeutic Strategies in Multiple Myeloma:

Targeting FGFR3.

This study is likely to provide

information about the role of the protein FGFR3 in

causing multiple myeloma. The research may also

provide new strategies to improve treatment

outcomes, since about 15 percent of myeloma

patients have a genetic abnormality that causes

inappropriate FGFR3 expression.

“

”

judy’s story

I began suffering from health issues in 1999, but

it took two years of specialists and complicated

tests to come up with the devastating diagnosis:

multiple myeloma. Thankfully, the Society was

there, helping me make informed decisions about

my care and making it easier for me to explain

myeloma to my concerned friends and family.

• Judy Dixon, myeloma survivor

“

”

Our Translational Research Program grant

from the Society is helping us conduct

clinical trials of patients with B cell malignancies

who are resistant to rituximab.

If we’re successful, we’ll be able to arm patients’

T killer cells with the targeting antibodies

and improve their survival and decrease relapse.

Lawrence Lum, M.D., Roger Williams Medical Center

10 11

2005 | ANNUAL REPORT

2005 blood cancer

highlights

research

In addition to funding research focused on speciﬁc

blood cancers, the Society invests in research that holds

promise for ﬁnding cures and improved therapies across

the entire blood cancer spectrum. The following are

examples of important studies:

■

Jose Villadangos, Ph.D., Walter & Eliza Hall Institute

of Medical Research, received a Career Development

Program (CDP) grant to study the

Control of Antigen

Presentation, Cross-Presentation and Migration in

Dendritic Cells.

He is studying one way in which our

immune system can ﬁght cancer. This involves

anti-cancer “killer” T cells that are recruited by other

immune system cells known as dendritic cells (DC).

These cells take parts of cancer cells, break them into

smaller pieces and display these pieces to the killer

cells, which recognize them. The killer cells then seek

and destroy other, related cancer cells. However,

cancer cells sometimes avoid detection by dendritic

cells, and then a tumor can expand. To get around this

limitation, Dr. Villadangos will obtain dendritic cells

from patients and put them in the test tube with

cancer cell pieces to generate “DC vaccines.” The

vaccines can then be re-introduced to patients to

activate anti-cancer killer cells. He will learn how the

dendritic cells obtain the cancer cell pieces, process

them and display them on their surfaces. This

knowledge is likely to improve methods for generating

DC vaccines that will have broad applications in

anti-cancer therapies.

■

David Scadden, M.D., Massachusetts General Hospital,

received a Translational Research Program grant for

the study

Therapeutic Manipulation of the Stem Cell

Niche.

Hematopoietic stem cells are the cells from

which all normal red and white blood cells derive, and

adult stem cell transplantation is an important therapy

for individuals with advanced leukemia, lymphoma or

myeloma. Unfortunately, transplant success depends

in part on the number of stem cells that can be

recovered from donors, and blood stem cells are rare.

Dr. Scadden has discovered a drug, parathyroid

hormone (PTH), that might increase pre-transplant

stem cell harvests. Dr. Scadden and his colleagues

will test the effect of PTH on the number of adult

blood stem cells in a mouse transplant model and in

human patients. If PTH treatment increases the stem

cell recovery rate, it could be used to improve the

successful application of stem cell transplants for

hematologic malignancies.

■

David Weinstock, M.D., Memorial Sloan-Kettering

Cancer Center, received a CDP grant to study

the chromosomal breakage and exchange that

results in an abnormality called a “translocation,”

commonly found in various types of blood cancers.

The

Chromosomal Translocations after RAG-Mediated

DNA Double Strand Breaks

project is aimed at

understanding how chromosome breaks occur and

how normal cells repair them. Using a novel system

they have developed, Dr. Weinstock and his group

will determine which proteins prevent and which

ones facilitate translocation formation. In addition,

they will study how chemotherapies for various

human cancers can promote translocation formation,

producing secondary blood cancers. The ultimate goal

of this project is to be able to prevent chromosome

translocations and block blood cancer formation.

patient services

In addition to disease-speciﬁc information and services,

the Society provides resources of relevance and interest

to all blood cancer patients. This is a small sample

of programs and materials made available this year:

■

Breaking Through the Age Barrier: Getting the

Best Cancer Treatment,

is a series of chapter-based

educational workshops launched this year. More than

half of all cancers occur in people older than 65, and

these patients may need special attention when it

comes to cancer treatment. The program helps deter

the outdated notion that people in this age group

are “too old” to beneﬁt from therapies that are

standard for younger segments of the population.

The workshops familiarize older blood cancer patients

and their caregivers with information on treatments

to help them communicate more effectively with

healthcare professionals. The Comprehensive Geriatric

Assessment, a checklist to help oncologists evaluate

older patients’ capacity to undergo treatment and side

effects, was introduced as part of this program.

■

Also published this year is A Toolkit for Older

Adults with Cancer and Their Caregivers,

which

includes booklets on choosing a healthcare team,

understanding treatment options, clinical trials and

ﬁnancial matters; and a guide to help caregivers

understand the ins and outs of their important role.

■

Cognitive and Late Effects Related to Childhood

Cancer

is a teleconference education program

featuring Daniel Armstrong, Ph.D., University of Miami

School of Medicine. In this program, Dr. Armstrong

discusses new research on the potential long-term

effects of cancer treatment on a child’s ability to learn

and, eventually, to work and participate in social

relationships. The potential effects of chemotherapy

and radiation therapy were discussed, along with

some of the educational and pharmaceutical

measures being used to address cognitive problems

that can result from cancer treatment. The special

needs of these children with respect to individualized

education plans were also addressed.

advocacy

Advocates for blood cancer patients faced many

legislative challenges in 2005, but the Society was

ready, scoring some notable successes for cancer

research and education.

Our advocacy efforts strengthened in March during

the annual Mission Day in Washington, D.C.

More than 250 Society supporters lobbied legislators

to increase funding for various medical programs

important to cancer patients.

Their efforts paid off. Despite signiﬁcant federal budget

cuts, the Society was able to secure an additional $5

million for blood cancer research at the U.S. Department

of Defense, and an additional $5 million for blood

cancer education provided by the Centers for Disease

Control and Prevention.

The Society’s free information programs and

services for blood cancer patients, their families

and caregivers are accessible in a variety

of user-friendly venues:

■

Call (800) 955-4572 or email

(infocenter@LLS.org) an information

specialist at our Information Resource Center

■

Visit our Web site at www.LLS.org

■

Learn the latest about any of the blood cancers

through our online education workshops and

teleconferences, archived on our Web site

■

Visit or contact any of our 66 chapters in the

United States and Canada, providing information

and support services at the community level

2005 | ANNUAL REPORT

2005 fundraising

highlights

12 13

light the night

Light The Night Walk continued its impressive growth

as a leading national charity walk. Launched in 1998,

Light The Night is held every fall in communities

across the United States and Canada, celebrating

and commemorating lives touched by cancer. In ﬁscal

year 2005, nearly 175,000 people participated — the

most ever — raising $25 million to help advance the

Society’s mission — a 36 percent increase over the

previous year. The Society also welcomed Ray Evernham,

NASCAR great and long-time Society friend, as national

Light The Night chairperson. Evernham’s popularity and

prestige in the sport helped promote Light The Night to

the huge NASCAR audience.

team in training

Team In Training (TNT), the world’s largest endurance

sports training program, enjoyed its best year ever.

More than 35,000 purple-clad TNT runners, walkers,

cyclists and triathletes participated in over 60 events

around the country, raising nearly $98 million

to help advance the Society’s mission. A milestone

was reached last October when 9,000 runners and

walkers raised $10 million at The Nike 26.2, A Marathon

for Women to Beneﬁt The Leukemia & Lymphoma

Society. The inaugural event, since renamed the Nike

Women’s Marathon, achieved two important “ﬁrsts”: the

ﬁrst marathon dedicated to a single charity and the ﬁrst

marathon in which all participants had the opportunity

to raise funds to help the Society ﬁnd cures for cancer.

school and youth

School & Youth

Programs offer children hands-on

experiences that cultivate caring, respect and the value

of helping others while raising much-needed funds

to help advance our mission. In 2005, 18 percent of all

schools nationwide (kindergarten through 12th grade)

— the most ever — signed up to participate in School

& Youth’s Pennies for Patients

, Pasta for Patients and

HOP for Leukemia & Lymphoma

. Soccer Kicks for

Cancer

, the newest School & Youth addition, geared

toward young soccer players, continued its national

expansion.

donor development

The Society’s dynamic research programs depend

on the contributions of generous donors. Fiscal

year 2005 was no exception. Donor development

revenue increased to more than $25 million —

a 38 percent increase in a single year. The gifts

contributed to funding such Society research initiatives

as the Specialized Center of Research, Translational

Research Program and Career Development grants,

as well as chapter and Home Ofﬁce-based patient

service programs.

Specialized Center of Research

Jerry Adams, PhD • 2002

Walter & Eliza Hall Institute

of Medical Research

Irwin D. Bernstein, MD

•

2003

Fred Hutchinson Cancer

Research Center

John Bushweller, PhD

•

2005

University of Virginia

John C. Byrd, MD

•

2006

The Ohio State University

Selina Chen-Kiang, PhD

•

2001

Weill Medical College

of Cornell University

Riccardo Dalla-Favera, MD

•

2004

Columbia University

Brian J. Druker, MD

•

2006

Howard Hughes Medical Institute

Oregon Health & Science University

Cancer Institute

James Grifﬁn, MD

•

2006

Dana-Farber Cancer Institute

Helen Heslop, MD

•

2004

Baylor College of Medicine

Carl June, MD

•

2002

University of Pennsylvania

Thomas J. Kipps, MD, PhD

•

2006

University of California, San Diego

Ronald Levy, MD

•

2006

Stanford University School of Medicine

Scott Lowe, PhD

•

2004

Cold Spring Harbor Laboratory

Tak Mak, PhD

•

2005

Advanced Medical Discovery Institute

University of Toronto, Canada

Stephen Nimer, MD

•

2002

Memorial Sloan-Kettering Cancer Center

Cheryl L. Willman, MD

•

2006

University of New Mexico

Health Sciences Center

Career Development Program:

Scholars

Peter Adams, PhD

•

2004

Fox Chase Cancer Center

David Allman, PhD

•

2005

University of Pennsylvania

Francisco Asturias, PhD

•

2002

Scripps Research Institute

Susan Biggins, PhD

•

2006

Fred Hutchinson Cancer

Research Center

Katherine Borden, PhD

•

2001

University of Montreal, Canada

James Bowie, PhD

•

2002

University of California, Los Angeles

Randy Brutkiewicz, PhD

•

2004

Indiana University School of Medicine

Anthony Capobianco, PhD

•

2002

Wistar Institute

J. Don Chen, PhD

•

2001

University of Medicine and Dentistry

of New Jersey

Zhijian Chen, PhD

•

2003

University of Texas

Genhong Cheng, PhD

•

2001

University of California, Los Angeles

Karlene Cimprich, PhD

•

2005

Stanford University School of Medicine

Pamela Correll, PhD

•

2003

Pennsylvania State University

Patricia Cortes, PhD

•

2002

Mount Sinai School of Medicine

Chris Counter, PhD

•

2003

Duke University Medical Center

John Crispino, PhD

•

2006

University of Chicago

Blossom Damania, PhD

•

2006

University of North Carolina

at Chapel Hill

James DeGregori, PhD

•

2001

University of Colorado

Health Sciences Center

Wei Du, PhD

•

2004

University of Chicago

Michael Eck, MD, PhD

•

2003

Dana-Farber Cancer Institute

Christine Eischen, PhD

•

2005

University of Nebraska Medical Center

Xin-Hua Feng, PhD

•

2004

Baylor College of Medicine

Margaret Goodell, PhD

•

2002

Baylor College of Medicine

Jonathan Graff, MD, PhD

•

2002

University of Texas

H. Leighton Grimes, PhD

•

2006

University of Louisville

Wei Gu, PhD

•

2002

Columbia University

Xi He, PhD

•

2006

Children’s Hospital Boston

Theodore Jardetzky, PhD

•

2002

Northwestern University

Jin Jiang, PhD

•

2004

University of Texas

Dong-Yan Jin, MD, PhD

•

2002

University of Hong Kong

Craig Jordan, PhD

•

2004

University of Rochester

Jae Jung, PhD

•

2001

New England Regional Primate

Research Center

Scott Keeney, PhD

•

2006

Memorial Sloan-Kettering Cancer Center

Michelle Kelliher, PhD

•

2004

University of Massachusetts

Medical School

William Kerr, PhD

•

2003

University of South Florida

Nigel Killeen, PhD

•

2001

University of California, San Francisco

Scott Kogan, MD

•

2005

University of California, San Francisco

Anthony Koleske, PhD

•

2003

Yale University

Kerry Kornfeld, MD, PhD

•

2002

Washington University

Stephen Kron, MD, PhD

•

2003

University of Chicago

Matthew Krummel, PhD

•

2006

University of California, San Francisco

Gustavo Leone, PhD

•

2005

The Ohio State University

Daniel Lew, PhD

•

2001

Duke University Medical Center

Xin Lin, PhD

•

2005

University of Texas

Hsiou-Chi Liou, PhD

•

2001

Weill Medical College

of Cornell University

Fenyong Liu, PhD

•

2002

University of California, Berkeley

Clifford Lowell, MD, PhD

•

2002

University of California, San Francisco

Hiten Madhani, MD, PhD

•

2006

University of California, San Francisco

Andreas Matouschek, PhD

•

2003

Northwestern University

Danesh Moazed, PhD

•

2004

Harvard Medical School

George Mosialos, PhD

•

2005

Biomedical Sciences Research Center

Matthew O’Connell, PhD

•

2001

Mount Sinai School of Medicine

David Pellman, MD

•

2001

Dana-Farber Cancer Institute

Christoph Plass, PhD

•

2003

The Ohio State University

Ishwar Radhakrishnan, PhD

•

2005

Northwestern University

Linda Resar, MD

•

2006

Johns Hopkins University

School of Medicine

Theodora Ross, MD, PhD

•

2006

University of Michigan Medical Center

Guy Sauvageau, MD, PhD

•

2003

University of Montreal, Canada

Stephen Schoenberger, PhD

•

2006

La Jolla Institute for Allergy

and Immunology

Ralph Scully, MD, PhD

•

2006

Beth Israel Deaconess Medical Center

David Seldin, MD, PhD

•

2001

Boston Medical Center

David Sharp, PhD

•

2005

Albert Einstein College of Medicine

Ali Shilatifard, PhD

•

2002

Saint Louis University

School of Medicine

Ramesh Shivdasani, MD,

PhD

•

2001

Dana-Farber Cancer Institute

Peter Sicinski, MD, PhD

•

2006

Dana-Farber Cancer Institute

Tomasz Skorski, MD, PhD

•

2001

Temple University

Reshma Taneja, PhD

•

2003

Mount Sinai School of Medicine

William Tansey, PhD

•

2002

Cold Spring Harbor Laboratory

* The year displayed after each grant represents

the ﬁrst year of grant activity.

The Specialized Center of Research Program

is supported in part by The John and Frances

Beck Family Foundation and General Motors.

Dr. Jerry Adams is funded in part by Eli Lilly

and Company.

Dr. Irwin Bernstein is funded by an

anonymous donor.

research

grants*

Dr. John Bushweller is funded in part by

the Peter Berg Memorial Research Fund.

Dr. John Byrd is funded in part by Douglas

and Phyllis Smith, Elaine S. Smith, Michael

Thomas and Joseph D. Johnson.

Dr. Riccardo Dalla-Favera is funded in part

from David and Diann Sant, Cathy and Scott

Zeilinger Philanthropic Fund, Lesley Goldwasser

and Jonathan Plutzik, Ruth and Carl Shapiro

Family Foundation, Deborah and Jeff Briggs,

Tracy and Frank Collins, James F. Egan, James

and Karen Finkel, Paul and Susan Friedman,

Jonathan and Jeannie Lavine and Family,

Tom Marano, Jeffrey and Katina Mayer, The

Edward L. Milstein Foundation, Michael and

Elin Nierenberg and Family, Daniel and Carol

Spina and Joseph S. and Diane H. Steinberg.

Dr. Brian Druker is funded in part by the

Bertelsen Family and the Kathy Soloff CML

Research Fund 2005.

Dr. James Grifﬁn is funded in part by the

Virginia Sheldon Jerome Foundation.

Dr. Carl June is funded in part by Lisa Bee.

Dr. Scott Lowe is funded in part by the Links

for Life-Cure Leukemia Foundation, the Alverin

M. Cornell Foundation and Valerie Aspinwall

& The Reichman Memorial/Altschul Foundation

and Kathy and Chip McNamara.

Dr. Stephen Nimer is funded in part by The

John and Shirley Davies Foundation.

Dr. Zhijian Chen is funded by the St. Valentine’s

Day Luncheon and Style Show.

Michael Teitell, MD, PhD

•

2004

University of California, Los Angeles

Dimitris Thanos, PhD

•

2001

Biomedical Sciences Research Center

Michael Thirman, MD

•

2003

University of Chicago

David Toczyski, PhD

•

2004

University of California, San Francisco

Toshio Tsukiyama, PhD, DVM

•

2003

Fred Hutchinson Cancer

Research Center

Jessica Tyler, PhD

•

2004

University of Colorado

Health Sciences Center

Katharine Ullman, PhD

•

2006

University of Utah

David Van Vactor, PhD

•

2001

Harvard Medical School

Jose Villadangos, PhD

•

2005

Walter & Eliza Hall Institute

of Medical Research

Claire Walczak, PhD

•

2002

Indiana University Medical Center

Xiaolu Yang, PhD

•

2005

University of Pennsylvania

Tso-Pang Yao, PhD

•

2004

Duke University Medical Center

Kyoko Yokomori, PhD, DVM

•

2001

University of California, Irvine

Hongtao Yu, PhD

•

2004

University of Texas

Weiguo Zhang, PhD

•

2005

Duke University Medical Center

Pengbo Zhou, PhD

•

2006

Weill Medical College

of Cornell University

Career Development Program:

Scholars in Clinical Research

Maurizio Bendandi, MD, PhD

•

2002

University of Navarra

Ravi Bhatia, MD

•

2003

City of Hope National Medical Center

Smita Bhatia, MD

•

2002

City of Hope National Medical Center

Robert Brodsky, MD

•

2001

Johns Hopkins Oncology Center

John C. Byrd, MD

•

2002

The Ohio State University

Martin Carroll, MD

•

2004

University of Pennsylvania

Kenneth Cooke, MD

•

2006

University of Michigan

Jorge Cortes, MD

•

2001

University of Texas

Glenn Dranoff, MD

•

2001

Dana-Farber Cancer Institute

Ephraim Fuchs, MD

•

2004

Johns Hopkins University

School of Medicine

Omer Koc, MD

•

2002

Case Western Reserve University

Zihai Li, MD, PhD

•

2006

University of Connecticut

Owen O’Connor, MD, PhD

•

2003

Memorial Sloan-Kettering Cancer Center

Robert Orlowski, MD, PhD

•

2006

University of North Carolina

at Chapel Hill

Aaron Rapoport, MD

•

2002

University of Maryland

Jeffrey Taub, MD

•

2003

Wayne State University

Children’s Hospital of Michigan

Christopher Walsh, MD, PhD

•

2001

Mount Sinai School of Medicine

Joseph Wiemels, PhD

•

2004

University of California, San Francisco

Career Development Program:

Special Fellows

Manzoor Ahmad, PhD

•

2003

National Institute of Allergy

& Infectious Disease

Laurie Ailles, PhD

•

2004

Stanford University

K. Mark Ansel, PhD

•

2006

CBR Institute of Biomedical

Research, Inc.

Toshiyuki Araki, PhD

•

2006

Beth Israel Deaconess Medical Center

Kamel Benlagha, PhD

•

2003

University of Chicago

Ittai Ben-Porath, PhD

•

2005

Whitehead Institute for Biomedical

Research

Klara Briknarova, PhD

•

2005

Burnham Institute

Katja Bruckner, PhD

•

2004

Harvard Medical School

Xin Chen, PhD

•

2006

Stanford University

Aiyang Cheng, PhD

•

2004

Yale University School of Medicine

Rafal Ciosk, PhD

•

2006

Fred Hutchinson Cancer

Research Center

Hilary Coller, PhD

•

2003

Princeton University

Sean Conner, PhD

•

2005

University of Minnesota, Twin Cities

Xu-Ming Dai, MD, PhD

•

2003

Albert Einstein College of Medicine

Nika Danial, PhD

•

2004

Dana-Farber Cancer Institute

Roberto De Guzman, PhD

•

2003

Scripps Research Institute

Zhong Deng, PhD

•

2006

Wistar Institute

Laxminarayana Devireddy,

PhD

•

2003

University of Massachusetts

Medical School

Joaquin Espinosa, PhD

•

2004

University of Colorado at Boulder

John Farrar, PhD

•

2002

University of Texas

Hui Feng, PhD

•

2006

Dana-Farber Cancer Institute

Josephine Ferreon, PhD

•

2006

Scripps Research Institute

Harold Fisk, PhD

•

2003

The Ohio State University

Elsa Flores, PhD

•

2004

University of Texas

Casey Fox, PhD

•

2005

University of Pennsylvania

Maxim Frolov, PhD

•

2003

University of Illinois at Chicago

Pierre-Henri Gaillard, PhD

•

2003

Scripps Research Institute

Julie Gates, PhD

•

2006

University of North Carolina

at Chapel Hill

Xinsheng Gao, PhD

•

2004

University of Texas

Marc Gavin, PhD

•

2004

University of Washington

Felicia Goodrum Flood, PhD

•

2004

Princeton University

Vanesa Gottifredi, PhD

•

2003

Fundacion Instituto Leloir

Karen Haas, PhD

•

2005

Duke University Medical Center

Tomoko Hamma, PhD

•

2006

Fred Hutchinson Cancer

Research Center

Joo Seok Han, PhD

•

2006

Ludwig Institute for Cancer Research

Azizul Haque, PhD

•

2004

Medical University of South Carolina

Kieran Harvey, PhD

•

2006

University of California, Berkeley

Beate Heissig, MD, PhD

•

2004

Juntendo University

Ke Hu, PhD

•

2006

Scripps Research Institute

Tara Huber, PhD

•

2006

Mount Sinai School of Medicine

Matthias Hundt, MD

•

2006

La Jolla Institute for Allergy

and Immunology

Lena Hwang, PhD

•

2003

University of California, San Francisco

Miho Iijima, PhD

•

2005

Johns Hopkins University

School of Medicine

Irena Ivanovska, PhD

•

2005

Whitehead Institute for Biomedical

Research

Julie Jameson, PhD

•

2004

Scripps Research Institute

Edith Janssen, PhD

•

2005

La Jolla Institute for Allergy

and Immunology

Sue Jaspersen, PhD

•

2005

Stowers Institute for Medical Research

Janusz Kabarowski, PhD

•

2003

University of Alabama at Birmingham

2005 | ANNUAL REPORT

Dr. Margaret Goodell, a Stephen Birnbaum

Scholar, is funded by The Stephen Birnbaum

Foundation.

Dr. Jonathan Graff is funded by the St. Valentine’s

Day Luncheon and Style Show.

Dr. Wei Gu is funded in part by the Wipe Out

Leukemia Forever Foundation, Inc.

Dr. Theodore Jardetzky is funded in part

by the Helen Brach Foundation.

Dr. Michelle Kelliher is funded by the

Gold-Diggers, Inc.

Dr. William Kerr is funded by The Newman

Foundation.

Dr. Scott Kogan is funded in part by The

San Francisco Foundation.

Dr. Kerry Kornfeld is funded by the Ed Heitz

Memorial Research Fund.

Dr. Stephen Kron is funded in part by

Vito Ippolito and Kathryn O’Connor-Ippolito.

Dr. Fenyong Liu is funded in part by the

Wayne and Gladys Valley Foundation.

Dr. Ali Shilatifard is funded by the Ed Heitz

Memorial Research Fund.

Dr. Michael Teitell is funded by Parents

Against Leukemia.

Dr. John Byrd is funded by the Bruce Bocina

Building Corp.

Dr. Joseph Wiemels is funded by Team Friends

of Allie-Honoring Sam Eisenberg and Allie

Scott.

Dr. Hillary Coller is funded by the Quest For

the Cure Research Fund.

Dr. Laxminarayana Devireddy is funded in

part by the Remillard Family Foundation, Inc.

Dr. Elsa Flores is funded by the Hildegarde

D. Becher Foundation.

Cheng-Fu Kao, PhD

•

2006

University of New Mexico

Chang Kim, PhD

•

2003

Purdue University

Alexei Kisselev, PhD

•

2002

Dartmouth College

Paul Knoepﬂer, PhD

•

2003

Fred Hutchinson Cancer

Research Center

Eric Lai, PhD

•

2005

Memorial Sloan-Kettering Cancer Center

Emma Langley, PhD

•

2006

Scripps Research Institute

Yvette Latchman, PhD

•

2003

Puget Sound Blood Center

Isabelle Le Blanc, PhD

•

2005

University of California, Berkeley

Ziqiang Li, PhD

•

2006

Albert Einstein College of Medicine

YuYao Liang, PhD

•

2006

University of Texas

Bin Liu, PhD

•

2003

University of California, Los Angeles

Jidong Liu, PhD

•

2006

Cold Spring Harbor Laboratory

Matthew Lorincz, PhD

•

2003

Fred Hutchinson Cancer

Research Center

Hinh Ly, PhD

•

2004

Emory University

Sami Malek, MD

•

2004

University of Michigan Medical School

Brendan Manning, PhD

•

2005

Harvard School of Public Health

Yinghui Mao, PhD

•

2005

Columbia University

Alberto Martin, PhD

•

2004

University of Toronto, Canada

Bernhard Mayr, MD

•

2003

Universitat Erlangen-Nuernberg

Brooke McCartney, PhD

•

2002

Carnegie Mellon University

Thomas Mercher, PhD

•

2006

Brigham and Women’s Hospital

Jung-Hyun Min, PhD

•

2005

Memorial Sloan-Kettering Cancer Center

Constantine Mitsiades, MD,

PhD

•

2004

Dana-Farber Cancer Institute

Massimo Morra, MD

•

200

Beth Israel Deaconess Medical Center

Raul Mostoslavsky, MD, PhD

•

2005

Harvard Medical School

Leon Murphy, PhD

•

2004

Harvard Medical School

Mikhail Nikiforov, PhD

•

2003

University of Michigan

Ryoma Ohi, PhD

•

2005

Harvard Medical School

Joseph Opferman, PhD

•

2005

Dana-Farber Cancer Institute

Sean O’Rourke, PhD

•

2006

University of Oregon

Amir Oryan (Orian), MD,

PhD

•

2005

Technion, Israel Institute of Technology

Laura Pasqualucci, MD

•

2003

Columbia University

Kathrin Plath, PhD

•

2005

Whitehead Institute for Biomedical

Research

Supriya Prasanth, PhD

•

2006

Cold Spring Harbor Laboratory

Jian Qu, PhD

•

2005

University of California, San Francisco

Yosef Refaeli, PhD

•

2003

National Jewish Medical

and Research Center

Inez Rogatsky, PhD

•

2003

Hospital for Special Surgery

Joan Roig Amoros, PhD

•

2003

Parc Cientiﬁc de Barcelona

Akihide Ryo, MD, PhD

•

2003

Yokohama City University

Hyung Ryoo, PhD

•

2006

New York University

School of Medicine

Shireen Saleque, PhD

•

2004

Children’s Hospital Boston

Adrian Salic, PhD

•

2006

Harvard Medical School

Tomoyuki Sawado, PhD

•

2005

Fred Hutchinson Cancer

Research Center

Jill Schweitzer, PhD

•

2004

University of Notre Dame

Clare Scott, MD, PhD

•

2004

Walter & Eliza Hall Institute of Medical

Research

Neil Shah, MD, PhD

•

2005

University of California, Los Angeles

Jeffrey Singer, PhD

•

2002

Brown University

Chi Wai So, PhD

•

2003

The Institute of Cancer Research

Yongcheng Song, PhD

•

2006

University of Illinois

at Champaign-Urbana

Eric Spierings, PhD

•

2005

Leiden University Medical Center

Walter Steiner, PhD

•

2005

Niagara University

Angela Stoddart, PhD

•

2005

University of Chicago

Valery Sudakin, DSC

•

2003

Fox Chase Cancer Center

Vinay Tergaonkar, PhD

•

2005

Salk Institute for Biological Studies

Scott Tibbetts, PhD

•

2004

Louisana State University

Benjamin Turk, PhD

•

2003

Yale University School of Medicine

Takehiko Usui, PhD

•

2005

Memorial Sloan-Kettering Cancer Center

Fred van Leeuwen, PhD

•

2004

Netherlands Cancer Institute

Gelin Wang, PhD

•

2004

University of Texas

Jing Wang, MD, PhD

•

2006

CBR Institute of Biomedical

Research, Inc.

Yanchang Wang, PhD

•

2002

Florida State University

Wenyi Wei, PhD

•

2006

Dana-Farber Cancer Institute

Orion Weiner, PhD

•

2005

University of California, San Francisco

Amy Weinmann, PhD

•

2004

University of Washington

Markus Welcker, PhD

•

2006

Fred Hutchinson Cancer

Research Center

Hans-Guido Wendel, MD

•

2006

Cold Spring Harbor Laboratory

Geng Wu, PhD

•

2006

Children’s Hospital Boston

Ting-Ting Wu, PhD

•

2002

University of California, Los Angeles

Zhaohui Wu, PhD

•

2006

University of Wisconsin, Madison

Ping Xie, PhD

•

2003

University of Iowa

Tomoki Yokochi, PhD

•

2006

Upstate Medical University

Akihiko Yokoyama, PhD

•

2006

Stanford University School of Medicine

Jianbo Yue, PhD

•

2006

Stanford University School of Medicine

Jinsong Zhang, PhD

•

2004

University of Cincinnati

Wei-Xing Zong, PhD

•

2004

University of Pennsylvania

Career Development Program:

Fellows

David Aiello, PhD

•

2005

University of Massachusetts

Medical School

Dikran Aivazian, PhD

•

2003

Stanford University School of Medicine

Jennifer Antonchuk, PhD

•

2004

University Hospital of Lund

Toshiyuki Araki, PhD

•

2003

Beth Israel Deaconess Medical Center

Bryan Barnhart, PhD

•

2006

University of Pennsylvania

Peggy Baudouin-Cornu, PhD

•

2004

Mount Sinai School of Medicine

Marie Bleakley, MD

•

2006

Fred Hutchinson Cancer

Research Center

Douglas Braaten, PhD

•

2003

Washington University

Benjamin Braun, MD, PhD

•

2004

University of California, San Francisco

Christine Brown, PhD

•

2001

City of Hope National Medical Center

Dr. Sami Malek is funded by The Hearst

Foundation, Inc.

research

grants continued

Dr. Amir Orian is funded by the Pamela

B. Katten Memorial Leukemia Research

Foundation.

Dr. Dikran Aivazian is funded in part by

Friends of Sue Rinsky.

Deirdre Buckley, PhD

•

2004

Cold Spring Harbor Laboratory

Kurt Cannon, PhD

•

2002

Harvard Medical School

Iris Chan, MD, PhD

•

2004

Brigham and Women’s Hospital

Danica Chen, PhD

•

2006

Massachusetts Institute of Technology

Jihua Chen, MD, PhD

•

2006

Dana-Farber Cancer Institute

Jing Chen, PhD

•

2005

Emory University

Dipanjan Chowdhury, PhD

•

2005

CBR Institute of Biomedical

Research, Inc.

Kent Christopherson, PhD

•

2004

University of Texas

Warren D’Souza, PhD

•

2006

University of California, San Diego

Zhong Deng, PhD

•

2003

Wistar Institute

Tracy Diamond, PhD

•

2006

University of Pennsylvania

Li-Lin Du, PhD

•

2003

Scripps Research Institute

Pinghui Feng, PhD

•

2004

New England Regional Primate

Research Center

Sylvia Fischer, PhD

•

2005

Massachusetts General Hospital

Timothy Fisher, PhD

•

2004

Princeton University

James Forrest, PhD

•

2005

Emory University

Joseﬁna Garcia, PhD

•

2006

Weill Medical College

of Cornell University

Tania Gourley, PhD

•

2004

Emory University

Yuli Guo, PhD

•

2003

Dana-Farber Cancer Institute

Jacob Harrison, PhD

•

2005

Brandeis University

John Hines, PhD

•

2003

Yale University

Amy Holdorf, PhD

•

2004

Mount Sinai School of Medicine

Eun-Jin Hong, PhD

•

2006

Harvard Medical School

Daniel Hostetter, PhD

•

2006

University of California, San Francisco

Kristen Hurov, PhD

•

2004

Dana-Farber Cancer Institute

Jonathan Irish, PhD

•

2006

Stanford University

Brenda Irvin, PhD

•

2003

Vanderbilt University

Kristen Johnson, PhD

•

2006

University of Chicago

Anna Keating, MD

•

2004

Memorial Sloan-Kettering Cancer Center

Karen Keeshan, PhD

•

2005

University of Pennsylvania

You-Me Kim, PhD

•

2004

Harvard Medical School

Sridevi Khambhampaty, PhD

•

2006

Stanford University School of Medicine

Marc Kvansakul, PhD

•

2006

Walter & Eliza Hall Institute

of Medical Research

Erica Larschan, PhD

•

2005

Brigham and Women’s Hospital

Dong Lee, PhD

•

2006

Salk Institute for Biological Studies

Mathew Lensch, PhD

•

2003

Children’s Hospital Boston

Xiaoling Li, PhD

•

2005

Massachusetts Institute of Technology

Zhe Li, PhD

•

2005

Children’s Hospital Boston

Xiaozhen Liang, PhD

•

2006

Harvard Medical School

Chinten Lim, PhD

•

2005

University of California, San Diego

Stephen Lin, PhD

•

2005

Dana-Farber Cancer Institute

Edward Luk, PhD

•

2006

National Institutes of Health

Julian Lum, PhD

•

2005

University of Pennsylvania

Eugene Makeyev, PhD

•

2005

Harvard University

Vanessa Marsden, PhD

•

2005

National Jewish Medical

and Research Center

Carla Martins, PhD

•

2006

University of California, San Francisco

Sebastiaan Meijsing, PhD

•

2005

University of California, San Francisco

Stavroula Mili, PhD

•

2006

Yale University School of Medicine

Shinichi Mizuno, MD, PhD

•

2004

Dana-Farber Cancer Institute

Alexandre Morozov, PhD

•

2006

Rockefeller University

Valerie Notenboom, PhD

•

2002

Netherlands Cancer Institute

Xuewen Pan, PhD

•

2004

Johns Hopkins University

School of Medicine

Sebastien Pfeffer, PhD

•

2005

Rockefeller University

Lisa Postow, PhD

•

2006

Rockefeller University

Natalie Prigozhina, PhD

•

2003

Scripps Research Institute

Martin Prlic, PhD

•

2006

University of Washington

Philippe Prochasson, PhD

•

2004

Stowers Institute for Medical Research

Ling Qi, PhD

•

2003

Salk Institute for Biological Studies

Bin Qian, PhD

•

2006

University of Washington

Priyamvada Rai, PhD

•

2006

Whitehead Institute for Biomedical

Research

John Randell, PhD

•

2004

Massachusetts Institute of Technology

Christopher Raymond, PhD

•

2003

Fred Hutchinson Cancer

Research Center

Lily Remsing Rix, PhD

•

2005

Center for Molecular Medicine

Stefan Riedl, PhD

•

2005

Burnham Institute

Adam Rosendorff, MD

•

2003

Brigham and Women’s Hospital

Stefanie Sarantopoulos, MD,

PhD

•

2006

Dana-Farber Cancer Institute

Joseph Scandura, MD, PhD

•

2003

Memorial Sloan-Kettering Cancer Center

David Schwartz, PhD

•

2003

Yale University

Gary Shapiro, PhD

•

2005

University of California, San Diego

Eric Shiozaki, PhD

•

2006

University of California, Los Angeles

Jonathan Snow, PhD

•

2006

Children’s Hospital Boston

Holger Sondermann, PhD

•

2003

University of California, Berkeley

Erinn Soucie, PhD

•

2006

IRIC – Institut de Recherche en

Immunovirologie et en ancerologie

Jason Tanny, PhD

•

2006

Rockefeller University

Vera Tarakanova, PhD

•

2006

Washington University in St. Louis

School of Medicine

Ewan Taylor, PhD

•

2006

Scripps Research Institute

Jorge Torres, PhD

•

2006

Stanford University School of Medicine

Su-Yi Tseng, PhD

•

2004

New York University

School of Medicine

Lidia Vasilieva, PhD

•

2005

Harvard Medical School

Li Wang, PhD

•

2004

Dartmouth College

Ying-Jie Wang, PhD

•

2004

University of Texas

David Weinstock, MD

•

2005

Memorial Sloan-Kettering Cancer Center

Richard Willis, PhD

•

2004

National Jewish Medical

and Research Center

Jasmine Wong, PhD

•

2006

University of California, San Francisco

Niels-Bjarne Woods, PhD

•

2005

Salk Institute for Biological Studies

Jingsong Xu, PhD

•

2003

University of California, San Francisco

2005 | ANNUAL REPORT

Dr. Deidre Buckley is funded by Mr. and

Mrs. Anthony Campbell and Mr. and Mrs.

Matthew Campbell.

Dr. Sebastien Pfeffer is funded by the Lehman

Brothers Foundation.

Dr. Joseph Scandura is funded by Michael

Copley and Leslie Elliot Krause, Esq., in

conjunction with Partners in Research.

Zheng Xu, PhD

•

2005

Beth Israel Deaconess Medical Center

Tingting Yao, PhD

•

2005

Stowers Institute for Medical Research

Ping Yuan, PhD

•

2006

Princeton University

Shan Zha, MD, PhD

•

2005

Harvard School of Medicine,

Children’s Hospital Boston

Jing Zhang, PhD

•

2004

Whitehead Institute for Biomedical

Research

Xiaowu Zhang, PhD

•

2003

Whitehead Institute for Biomedical

Research

Song Zhao, MD, PhD

•

2005

Memorial Sloan-Kettering Cancer Center

Rui Zhou, PhD

•

2005

Harvard Medical School

Daniel Zilberman, PhD

•

2006

Fred Hutchinson Cancer

Research Center

Weiguo Zou, PhD

•

2006

Scripps Research Institute

Translational Research Program

Vahid Afshar-Kharghan, MD • 2003

Baylor College of Medicine

Ricardo Aguiar, MD, PhD

•

2002

Dana-Farber Cancer Institute

Denis Alexander, PhD

•

2003

Babraham Institute

Stephen Ansell, MD, PhD

•

2004

Mayo Clinic and Foundation

Scott Armstrong, MD, PhD

•

2004

Children’s Hospital Boston

David Avigan, MD

•

2002

Beth Israel Deaconess Medical Center

David Avigan, MD

•

2005

Beth Israel Deaconess Medical Center

Maria Baer, MD

•

2003

Roswell Park Cancer Institute

Deborah Banker, PhD

•

2002

Fred Hutchinson Cancer

Research Center

Dwayne Barber, PhD

•

2005

Ontario Cancer Institute, Canada

Pamela Becker, MD, PhD

•

2006

University of Washington

Antonio Bedalov, MD, PhD

•

2006

Fred Hutchinson Cancer

Research Center

Steven Bernstein, MD

•

2004

University of Rochester

Steven Bernstein, MD

•

2006

University of Rochester

Ravi Bhatia, MD

•

2003

City of Hope National Medical Center

Smita Bhatia, MD

•

2002

City of Hope National Medical Center

Bruce Blazar, MD

•

2004

University of Minnesota, Twin Cities

Carl Borrebaeck, DSC

•

2006

Lund University

Roger Briesewitz, PhD

•

2005

The Ohio State University

John Bushweller, PhD

•

2002

University of Virginia

Janet Butel, PhD

•

2003

Baylor College of Medicine

John C. Byrd, MD

•

2005

The Ohio State University

Michael Caligiuri, MD

•

2006

The Ohio State University

Martin Carroll, MD

•

2004

University of Pennsylvania

Ethel Cesarman, MD, PhD

•

2002

Weill Medical College

of Cornell University

Preet Chaudhary, MD, PhD

•

2006

University of Pittsburgh

Wei Chen, MD, PhD

•

2005

University of Minnesota, Twin Cities

Selina Chen-Kiang, PhD

•

2006

Weill Medical College

of Cornell University

Linzhao Cheng, PhD

•

2002

Johns Hopkins University

School of Medicine

Jason Chesney, MD, PhD

•

2006

University of Louisville

Rachael Clark, MD, PhD

•

2006

Brigham and Women’s Hospital

Bayard Clarkson, MD

•

2004

Memorial Sloan-Kettering Cancer Center

Robert Collins, MD

•

2004

University of Texas

Steven Collins, MD

•

2004

Fred Hutchinson Cancer

Research Center

Kenneth Cooke, MD

•

2004

University of Michigan

Comprehensive Cancer Center

Laurence Cooper, MD, PhD

•

2003

City of Hope National Medical Center

Laurence Cooper, MD, PhD

•

2006

City of Hope National Medical Center

Richard D’Andrea, PhD

•

2004

Child Health Research Institute

Bryant Darnay, PhD

•

2002

University of Texas

Albert Deisseroth, MD, PhD

•

2004

Sidney Kimmel Cancer Center

Joseph DiCarlo, MD

•

2005

Stanford University

Clark Distelhorst, MD

•

2006

Case Western Reserve University

Dirk Dittmer, PhD

•

2006

University of North Carolina

at Chapel Hill

Nicholas Donato, PhD

•

2002

University of Texas

Ming-Qing Du, MD, PhD

•

2003

University of Cambridge

Ming-Qing Du, MD, PhD

•

2005

University of Cambridge

Dimitar Efremov, MD, PhD

•

2006

International Centre for Genetic

Engineering and Biotechnology

Elizabeth Eklund, MD

•

2002

Northwestern University

School of Medicine

Elizabeth Eklund, MD

•

2006

Northwestern University

School of Medicine

Stephen Emerson, MD, PhD

•

2005

University of Pennsylvania

Carolyn Felix, MD

•

2002

The Children’s Hospital of Philadelphia

Dean Felsher, MD, PhD

•

2004

Stanford University School of Medicine

Robert Fenton, MD, PhD

•

2004

University of Maryland

Daniel Fernandes, PhD, DSC

•

2006

Medical University of South Carolina

Adele Fielding, PhD

•

2003

Mayo Clinic and Foundation

Barry Finette, MD, PhD

•

2003

University of Vermont

Christopher Flowers, MD

•

2006

Emory University

Francine Foss, MD

•

2003

Tuffs University

New England Medical Center

Arthur Frankel, MD

•

2005

Scott and White Memorial

Hospital and Clinic

Ephraim Fuchs, MD

•

2002

Johns Hopkins University

School of Medicine

Varsha Gandhi, PhD

•

2005

University of Texas

Irene Ghobrial, MD

•

2006

Dana-Farber Cancer Institute

Spencer Gibson, PhD

•

2005

University of Manitoba, Canada

Spencer Gibson, PhD

•

2002

University of Manitoba, Canada

D. Gary Gilliland, MD, PhD

•

2003

Howard Hughes Medical Institute

Brigham and Women’s Hospital

Harvard Medical School

D. Gary Gilliland, MD, PhD

•

2006

Howard Hughes Medical Institute

Brigham and Women’s Hospital

Harvard Medical School

Jianlin Gong, MD

•

2004

Boston University

Steven Gore, MD

•

2005

Johns Hopkins University

School of Medicine

Stephen Gottschalk, MD

•

2004

Baylor College of Medicine

Steven Grant, MD

•

2003

Virginia Commonwealth University

Steven Grant, MD

•

2006

Virginia Commonwealth University

Ian Harmer, PhD

•

2003

University of Cambridge

Charles Hemenway, MD,

PhD

•

2005

Tulane University School of Medicine

Dr. Vahid Afshar-Kharghan is funded by the

MPD Foundation in partnership with Friends

of Essential Thrombocythemia, Inc. and The

Leukemia & Lymphoma Society.

Dr. Stephen Ansell is funded in part by

Phyllis Rubinstein in honor of Lisa Mulman.

Dr. Scott Armstrong is funded by the Connors

Family Charitable Fund, Jack and Eileen

Connors, Willy’s Fund and the William Wesley

Kelly Research Fund.

research

grants continued

Dr. Roger Briesewitz is funded in part by the

Friends of Jeff Sachs.

Dr. John Byrd is funded by Stephen and

Madeleine Anbinder and In memory

of Andrew C. Renz, M.D.

Dr. Robert Collins is funded by the St.

Valentine’s Day Luncheon and Style Show.

Dr. Steven Collins is funded by the Quest

For the Cure Research Fund.

Dr. Laurence Cooper is funded by The Gail

Cohen Leukemia Fund.

Dr. Joseph DiCarlo is funded in part by the

Mario Lemieux Foundation.

Dr. Stephen Emerson, a Stephen Birnbaum

Scholar, is funded by The Stephen Birnbaum

Foundation.

Dr. Dean Felsher is funded in part by the

Valentine Foundation.

Dr. Varsha Ghandi is funded by the Jim Jacobs

Leukemia Research Fund.

Dr. Charles Hemenway is funded in part by

Anabel Wheeler, Bob Gadomski, Shahan

and Camilla Soghikian.

Dr. Craig Jordan is funded in part by the

Douglas Kroll Research Program.

2005 | ANNUAL REPORT

Craig Jordan, PhD

•

2006

University of Rochester

Scott Kaufmann, MD, PhD

•

2005

Mayo Clinic and Foundation

Thomas Kipps, MD, PhD

•

2004

University of California, San Diego

Krishna Komanduri, MD

•

2006

University of Texas

Marina Konopleva, MD, PhD

•

2002

University of Texas

Steven Kornblau, MD

•

2003

University of Texas

Steven Kornblau, MD

•

2006

University of Texas

Simon Lacey, PhD

•

2002

Beckman Research Institute

Simon Lacey, PhD

•

2005

Beckman Research Institute

Jill Lacy, MD

•

2004

Yale University School of Medicine

Uma Lakshmipathy, PhD

•

2004

University of Minnesota, Twin Cities

Lawrence Lamb, PhD

•

2003

University of Alabama at Birmingham

Charles Lee, PhD

•

2005

Brigham and Women’s Hospital

Robert Lee, PhD

•

2002

The Ohio State University

Hyam Levitsky, MD

•

2005

Johns Hopkins University School

of Medicine

Jane Liesveld, MD

•

2004

University of Rochester

Michael Lilly, MD

•

2002

Loma Linda University

Bing Lim, MD, PhD

•

2003

Beth Israel Deaconess Medical Center

Jose Lopez, MD

•

2005

Baylor College of Medicine

Lawrence Lum, MD, DSC

•

2005

Roger Williams Medical Center

Guitta Maki, PhD

•

2003

Rush University Medical Center

Otoniel Martinez-Maza, PhD

•

2003

University of California, Los Angeles

Hector Martinez-Valdez, MD,

PhD

•

2003

University of Texas

Kenneth Meehan, MD

•

2006

Dartmouth-Hitchcock Medical Center

Ari Melnick, MD

•

2006

Albert Einstein College of Medicine

David Miklos, MD, PhD

•

2006

Stanford University

Research Cancer Center

Wilson Miller, MD, PhD

•

2003

Jewish General Hospital, Lady Davis

Institute for Medical Research, Canada

Mark Minden, MD, PhD

•

2003

Ontario Cancer Institute, Canada

Shakeel Modak, MD, PhD

•

2004

Memorial Sloan-Kettering Cancer Center

Malcolm Moore, MD

•

2006

Memorial Sloan-Kettering Cancer Center

Benjamin Neel, MD, PhD

•

2004

Beth Israel Deaconess Medical Center

Susan Nilsson, PhD

•

2004

Peter MacCallum Cancer Institute

Lawrence Panasci, MD

•

2006

Lady Davis Institute for Medical

Research, Canada

Peter Parham, PhD

•

2004

Stanford University School of Medicine

Roger Pearse, MD, PhD

•

2006

Weill Medical College of Cornell

University

Christoph Plass, PhD

•

2005

The Ohio State University

Jonathan Pollack, MD, PhD

•

2006

Stanford University

Miles Prince, MD

•

2005

Peter MacCallum Cancer Centre

Miles Prince, MD

•

2006

Peter MacCallum Cancer Centre

Louise Purton, PhD

•

2003

Peter MacCallum Cancer Institute

Shahin Raﬁi, MD

•

2004

Weill Medical College

of Cornell University

S. Vincent Rajkumar, MD

•

2003

Mayo Clinic and Foundation

Yosef Refaeli, PhD

•

2006

National Jewish Medical

and Research Center

Dirk Reinhardt, MD

•

2002

Universitätsklinikum Münster

Alain Rook, MD

•

2002

University of Pennsylvania

Alain Rook, MD

•

2005

University of Pennsylvania

Cliona Rooney, PhD

•

2002

Baylor College of Medicine

Janet Rowley, MD

•

2006

University of Chicago

Felipe Samaniego, MD

•

2006

University of Texas

David Scadden, MD

•

2005

Massachusetts General Hospital

Aaron Schimmer, MD, PhD

•

2004

Princess Margaret Hospital, Canada

Stephen Schuster, MD

•

2002

University of Pennsylvania

Stephen Schuster, MD

•

2006

University of Pennsylvania

Oliver Semmes, PhD

•

2003

Eastern Virginia Medical School

Judith Shizuru, MD, PhD

•

2003

Stanford University

Sherrill Slichter, MD

•

2002

Puget Sound Blood Center

and Program

Florence Smadja, PhD

•

2003

Institut Universitaire d’hématologie

Donald Small, MD, PhD

•

2004

Johns Hopkins University

Mitchell Smith, MD, PhD

•

2003

Fox Chase Cancer Center

Lloyd Stoolman, MD

•

2004

University of Michigan

Alison Stopeck, MD

•

2002

Arizona Cancer Center

Moshe Talpaz, MD

•

2004

University of Texas

Ana Tari, PhD

•

2006

University of Texas

Michael Thirman, MD

•

2005

University of Chicago

John Timmerman, MD

•

2006

University of California, Los Angeles

Michael Tomasson, MD

•

2003

Washington University

Max Topp, MD

•

2004

University of Wuerzburg

Joseph Tuscano, MD

•

2004

University of California, Davis

Marcel van den Brink, MD,

PhD

•

2006

Memorial Sloan-Kettering Cancer Center

Andrea Velardi, MD

•

2002

Università di Perugia

Edmund Waller, MD, PhD

•

2002

Emory University

J. Brice Weinberg, MD

•

2006

Duke University Medical Center

David Williams, MD

•

2006

Cincinnati Children’s Hospital

Medical Center

Xiao-Feng Yang, MD, PhD

•

2004

Baylor College of Medicine

Qing Yi, MD, PhD

•

2003

University of Texas

Muxiang Zhou, MD

•

2005

Emory University

Dr. Scott Kaufmann is funded by Clyde

McGregor and Joan Kowling McGregor.

Dr. Hyam Levitsky is partially funded

by Milton Lichtman.

Dr. Jane Liesveld is funded in part by the

Douglas Kroll Research Program.

Dr. Shakeel Modak is funded by an

anonymous donor.

Dr. Peter Parham is funded in part by

Mrs. Dee Sanﬁlippo.

Dr. Christoph Plass is funded by Stephen

and Madeline Anbinder.

Dr. Shahin Raﬁi is funded by the Douglas

Kroll Research Program.

Dr. Janet Rowley is funded by The Coleman

Foundation.

Dr. David Scadden is funded by the F.M.

Kirby Foundation.

Dr. Aaron Schimmer is funded in part by

John R. Jones, Jr. and In memory of Diane

Sierzega Ware.

Dr. Judith Shizuru is funded by an anonymous

donor.

Dr. Sherrill Slichter is funded by the Quest

For the Cure Research Fund.

Dr. Donald Small is funded by the Douglas

Kroll Research Program.

Dr. Mitchell Smith is funded by an anonymous

donor.

Dr. Michael Thirman is funded by The Coleman

Foundation.

Dr. Michael Tomasson is funded in part by the

Links for Life-Cure Leukemia Foundation.

Dr. Andrea Velardi is funded by an anonymous

donor.

Dr. Xiao-Feng Yang is funded by the MPD

Foundation in partnership with Friends

of Essential Thrombocythemia, Inc. and

The Leukemia & Lymphoma Society.

Beverly S. Mitchell, MD

•

Chair *

Cancer Research Center

Stanford University

Armand Keating, MD

•

Vice Chair

Princess Margaret Hospital

Irwin D. Bernstein, MD

Fred Hutchinson Cancer

Research Center

David Bodine, PhD

National Institutes of Health

Selina Chen-Kiang, PhD

Weill Medical College

of Cornell University

Curt I. Civin, MD

Johns Hopkins Comprehensive

Cancer Center

Brian J. Druker, MD

Howard Hughes Medical Institute

Oregon Health & Science University

Cancer Institute

Alan M. Gewirtz, MD *

University of Pennsylvania

School of Medicine

D. Gary Gilliland, MD, PhD

Howard Hughes Medical Institute

Brigham and Women’s Hospital

Harvard Medical School

James Grifﬁn, MD

Dana-Farber Cancer Institute

Judith E. Karp, MD

The Bunting Blaustein Cancer

Research Building

Michael W. Long, PhD *

Velcura Therapeutics, Inc.

W. Stratford May, MD, PhD *

University of Florida

Warren S. Pear, MD, PhD

Abramson Family Cancer

Research Institute

Kanti R. Rai, MD

Long Island Jewish Medical Center

Joel Rappeport, MD

Yale School of Medicine

Steven T. Rosen, M.D

Robert H. Lurie Comprehensive

Cancer Center

Naomi Rosenberg, PhD *

Tufts University School of Medicine

Margaret A. Shipp, MD

Dana-Farber Cancer Institute

Guido J. Tricot, MD, PhD

University of Arkansas

for Medical Sciences

Cheryl L. Willman, MD

University of New Mexico

Health Sciences Center

Irwin D. Bernstein, MD

•

Chair

Fred Hutchinson Cancer

Research Center

Selina Chen-Kiang, PhD

Weill Medical College

of Cornell University

Brian J. Druker, MD

Howard Hughes Medical Institute

Oregon Health & Science University

Cancer Institute

Judith E. Karp, MD

The Bunting Blaustein Cancer

Research Building

Michael W. Long, PhD

Velcura Therapeutics, Inc.

Beverly S. Mitchell, MD

Cancer Research Center

Stanford University

* Board of Directors

medical and

scientific advisors

professional

education subcommittee

endowment

funds

Charlotte Meyers Research Fund

de Villiers Endowment Fund

GlaxoSmithKline Foundation & GlaxoSmithKline, Inc. Research Fund

Jim Jacobs Leukemia Research Fund

Mary & Robert Bronstein Memorial Fund

The Rachel Kudish Fund

The Rae Endowment Fund

Reich Educational Fund

Thomas M. Ford Memorial Fund

The UFCW Endowment Fund

The Virginia Major Brooks Memorial Endowment Fund

Vrushali Ranadive Fellowship Fund

Joel Rappeport, MD

Yale School of Medicine

Margaret A. Shipp, MD

Dana-Farber Cancer Institute

Guido J. Tricot, PhD

University of Arkansas

for Medical Sciences

$1,000,000 and above

Anonymous

United Food & Commercial Workers

International Union (UFCW)

David and Diann Sant

$500,000 — $999,999

Bristol-Myers Squibb Company

Mr. and Mrs. Carl H. Lindner, Jr.

Novartis

$100,000 — $499,999

Anonymous – Maryland

Chapter Leader

Stephen and Madeline Anbinder

Valerie Aspinwall & The Reichman

Memorial/Altschul Foundation

The Bertelsen Family

The Stephen Birnbaum Foundation

Celgene Corporation

Centers for Disease Control

& Prevention

The Coleman Foundation

Community Health Charities

of Connecticut

Diamond Ball/Ed Heitz Memorial

Research Fund

Mr. and Mrs. Simon C. Fireman

General Motors Foundation

HCS Foundation

Virginia Sheldon Jerome

Foundation

William Wesley Kelly

Research Fund

F.M. Kirby Foundation, Inc.

Douglas Kroll Research Program

Susan Lang Foundation

Lehman Brothers Foundation

Rush Limbaugh

Mr. and Mrs. S. Craig Lindner

Links for Life – Cure Leukemia

Foundation

Clyde McGregor and Joan Kowling

McGregor

Kathy and Chip McNamara

The Newman Foundation

Quality Food Centers

Parents Against Leukemia

Peter Berg Memorial Research Fund

Dee Sanﬁlippo

Carl and Ruth Shapiro

Family Foundation

Douglas and Phyllis Smith

Michael Thomas

The Virginia Sheldon Jerome

Foundation

$50,000 — $99,999

Hildegarde D. Becher Foundation,

Inc.

The John and Frances Beck Family

Foundation

Berlex

The Bill Bernbach Foundation

Bost Custom Homes

Mr. and Mrs. Anthony Campbell

Mr. and Mrs. Matt Campbell

Chatham Development Corporation

Chicago Cosmetologists Association

Faro Foundation

Foxwood Homes, Inc.

Friends of Essential

Thrombocythemia, Inc.

Genzyme

GlaxoSmithKline

Lesley Goldwasser and Jonathan

Plutzik

The Jeff Gordon Foundation

Pete Harman

The Hearst Foundation, Inc.

The Hollander Foundation

IDEC

Jim Jacobs Charitable Foundation

Pamela B. Katten Memorial

Leukemia Research Foundation

The Krutz Foundation

The Mario Lemieux Foundation

Mr. and Mrs. Carl H. Lindner III

The Madoff Family

Millennium

MPD Foundation

Aldo Parcesepe

Parents Against Leukemia

Potawatomi Bingo Casino

Jacques and Marlene Rubin

The Victor E. and Caroline E. Schutte

Foundation – Trust E

Kathy Soloff CML Research Fund

Elaine S. Smith

Joseph S. and Diane H. Steinberg

The Mel Stottlemyre Myeloma

Foundation

Wayne and Gladys Valley Foundation

Windward Homes

Wish Upon A Star Gala 2005

Balloons

$10,000 — $49,999

Acco Brands, Inc.

Breeden Adams Foundation

Alabama Power Foundation

Amgen

Anonymous

Ham Ansley Memorial Research Fund

APCI Rock the Night

Lance Armstrong Foundation

Mary J. Arnett Trust

Mr. and Mrs. James Ashworth

Atlanta Thrashers Foundation

The Sandra Atlas Bass & Edythe

& Sol G. Atlas Fund, Inc.

Auburn Panhellenic Council

Bank of America

Mrs. Angie Barrett

John and Eileen Barrett

Mr. Doug Baughman

Bears Care Fund, a Fund of

The Robert R. McCormick

Tribune Foundation

Mr. and Mrs. Joseph and Judith

Becelia

Lisa Bee

BellSouth

Beloved Dawgs Dinner

Benjamin Moore Paints

Jay H. Bernstein

Jack Berkowitz CMML

Research Fund

Alice Ann Bien Foundation

Bioenvision

Biogen Idec

Alexandra Mayes Birnbaum

Stephen and Mary Birch Foundation,

Inc.

Murray Blackman

BlueCross/BlueShield Of Alabama

Anna and David Blumenfeld

Mr. and Mrs. Edward Blumenfeld

Bruce Bocina Building Corp.

Boeing Employees Community Fund

Boeing Houston Employees

Community Fund

Ted Bollin

Steve Boom

Helen Brach Foundation

In Memory of Emerson B. Bridges

Eli & Edythe L. Broad Foundation

Edgar and Clarissa Bronfman

Alex Brown & Sons Charitable

Foundation

Stanley E. Brown Family Foundation

C. Scott Bruin

Burlington Coat Factory (No. 165)

Burlington Coat Factory (No. 190)

Ms. Gwynnae Byrd

Florentine Camenisch Trust

Campbell & Company

J. Terence and Sharon Carleton

Wayne and Fran Carlisle

Glenn and Lynne Carlson

The Ronald Harlin Carr Foundation

The Castellini Foundation

Cephalon

Challenging the Course of Cancer

Thomas Chapman

Children’s Charities Foundation

David and Mary Christensen

CIBC World Market Corp Miracle

Day USA Account

Cinergy

Bruce and Isobel Cleland

Gail Cohen Leukemia Fund

Community Health Charities

of Arizona

Community Health Charities

of California

Community Health Charities

of Illinois

Community Health Charities

of Kentucky

Community Health Charities

of Wisconsin

Jack Connors

Connors Family Charitable Fund

Convergys Corporation

Michael and Elizabeth Copley

Alverin M. Cornell Foundation

Corporex Companies LLC

CSX Corporation

Danford Foundation

David Dashiell

The John and Shirley Davies

Foundation

Leona E. and Donald W. Davis

The Marc David Foundation

Mary Del Bene

France and Andre Desmarais

Donny Deutsch

Frank DiPascali

The Edgar Family Charitable Fund

John P. Eidel

Mr. and Mrs. Dennis and Dana

Eisenberg

2005 | ANNUAL REPORT

donors

Employees Community Fund

of Boeing St. Louis

Entergy Services, Inc

Elizabeth Fago

Fairway Lincoln-Mercury

Falk Family Foundation

Denni and Nicholas Ferrara

Fisher Chevrolet-Kia

Art and Gwen Flaming

Susan Fobes

Friends In Memory of Todd Alan

Whitman

Friends of Jeff Sachs

Friends of Ligonier Polo

Friends of Sean to Beneﬁt The

Leukemia & Lymphoma Society

Friends of Sue Rinsky

Fry Steel Company

Dorothy Fuqua

Brad Gadomski

Mariellen Gallagher

Melissa Gay

GE Corporate Financial Services

Genentech BioOncology

Genzyme

Dan and Debbie Gill

Jill Gimelli

The Gold-Diggers, Inc.

Samuel Goldberg & Sons

Foundation, Inc.

Steve Gottlieb

GPCA

Mark Grace Foundation

The Paul B. Greetin and

Beryl S. Greetin Foundation, Inc.

Marliss Gruver

Mr. Roger Guillaume, Jr.

Hakluyt & Company Limited

Health Care Reit

The Helis Foundation

Hendin Family

Michelle Henkel

Dulé Hill

Hills Development

History Heritage & Hope Foundation

Aaron and Susan Hollander

Larry Holste

Mike Hoover

Gene Hovanec

Hudson United Bank

ILEX Oncology, Inc.

Mr. and Mrs. Randall and

Stephanie Imhoff

Imlay Foundation

Independent Research Group

Insured Beneﬁt Plans, Inc.

Intergraph

Vito Ippolito and Kathryn

O’Connor-Ippolito

Alan K. & Cledith M. Jennings

Foundation

Jewish Federation of Greater

Philadelphia

JMB Hope Foundation

Joseph D. Johnson

John R. Jones, Jr.

Mr. and Mrs. Ralph C. and

Sally Jones

Kenneth and Karen Kaplan

David Adam Katz

Keating, Muething and Klekamp

PLL

Dr. Dean and Anne Kereiakes

Mr. and Mrs. Jack J. Kessler, Esq.

Digby Kirby

Kirshenbaum Bond & Partners

Klein Family Foundation

Paul Konigsberg, Esq.

Konigsberg Wolf & Co. PC

Rita and Gene Kelly

Pam and Keith Kelly

Mary Anne Kenny and Karen Powers

KLA Tencor Foundation

Charles Koller, MD

Krafty Ladies of Walnut Woods

Leslie Elliot Krause, Esq.

The Jean & E. Floyd Kvamme

Foundation

Marie Lamfrom Charitable

Foundation

Rob Larocque and Carol Clause

Richard Lavanture

LLB Golf Tournament

(O.E. Community Service Fund)

The Lebenfeld Foundation

The Tony Lefﬁngwell Foundation

Mr. and Mrs. George Lehman

Michael Lewin

Steven Lieblich

Mr. and Mrs. James and Jennifer

Lincoln

Mr. and Mrs. Keith E. Lindner

Milton Litchman

Local 148 Operating Engineers

Thomas J. Long Foundation

Stuart Lovett

Lowndes, Drosdick, Doster,

Kantor & Reed, PA

Larry Luke

James Mahlmeister

Manzi Family Charitable Foundation

Tom Marano

Richard and Christina Marcinek

Dr. and Mrs. Stanley Marks

Mr. and Mrs. Mark E. Mason

Jeffrey and Katina Mayer

MBM Corporation

Mr. and Mrs. Jack McDonald

The Laffey McHugh Foundation

Mellon Bank

Meyer Memorial Trust

Mr. and Mrs. Don and Martha Miller

Edward L. Milstein Foundation

The Sidney Milton & Leoma Simon

Foundation

David J. Mitchell

The Moody Foundation

Morgan Keegan & Co.

Robert Morrissey

Jim Morrison

Morrison Homes

Mike Munchak

National City

The Netter Foundation, Inc.

New England Patriots Foundation

Kenneth Newton

Joseph and Deborah Norberg

Northwestern Mutual Life

Foundation, Inc.

Option One Mortgage Corp.

Oracle Corporate Giving Program

The Oregon Community Foundation

Osprey Foundation

Panebraska LLC, a franchisee

of Panera LLC

The Hoyt & Viorica Pardee

Foundation

Park Place Dealerships

Partners Healthcare System

Penn Treaty Network America

People’s Bank

Richard Perlman

William L. Peters

Phi Gamma Delta

Philips Lighting

Ed & H Pillsbury Foundation

Pittsburgh Paint & Glass Company

Polsinelli Shalton Welte Suelthaus

Preferred Flooring

The Jim Quay Memorial Team

Rags For Riches Foundation

Remillard Family Foundation

In Memory of Andrew C. Renz, MD

James Resnick

Mariana Richards

Jim Riha

Art and Sue Rinsky

Rodman Ford Sales, Inc.

Martha W. Rogers Trust

William G. Rohrer Charitable

Foundation

Ronald McDonald House Charities

The Rosewood Corporation

Phyllis Rubinstein

Paul & Joan Rubschlager

Foundation

Thomas Ryan

Laura Landro Salomon and Richard

Salomon

The San Francisco Foundation

Annunziata Sanguinetti Foundation

Sarver Charitable Trust

Charles and Julie Scheper

Daniel and Andrea Schreiber

The Victor E. and Caroline E. Schutte

Foundation – 1959

Mr. and Mrs. Stephen A. Schwarzman

The Schwartz Family Foundation

Edith M. Schweckendieck Trusts

Renee and Stanley Shapiro

The Peter Jay Sharp Foundation

Frank Short

Robert and Pamela Sibey

Mace Siegel

In Memory of Diane Sierzega Ware

Sigma Alpha Epsilon Fraternity,

University of Georgia

Simpson Thacher & Bartlett

Shahan and Camilla Soghikian

Matthew Spitzer

State of New York Department

of Health on behalf of Senator

Carl Marcellino

State of New York Department

of Taxation and Finance on behalf

of Senator Charles Fuschillo

Garrett L. Stauffer, CPA

St. Joseph’s/Candler

John Stein

Marcie and Avy Stein

Dr. and Mrs. Paul and Kathy

Steinberg

donors continued

Sterling Equities

Dr. Peter J. Stern

Harry and Jo Ann Stoddard

Sheryl Stollof

Keith D. Stoltz Foundation

The Strain Foundation

Sugar Lakes Foundation

Dave C. Swalm

Swing For a Cure

J.T. Tai & Co Foundation, Inc.

Donald and Tracey Tandy

The Taylor Family Foundation

Mr. and Mrs. Gillis Thomas

Mary Lou Timpson

TJX Companies, Inc.

TrimQuest

Mr. and Mrs. Robert Tschudy

Two Sisters Gourmet

Ronald and Arleigh Tysoe

Marilyn Underhill

United Way of Delaware

United Way of New York City

Mr. and Mrs. Ron and Terry Unkefer

The Valentine Foundation

Vanguard Charitable Endowment / DE

E P Vaughhan Beneﬁciaries

c/o US Bank

Verizon Foundation

Victory Scramble Fore A Cure

Vredenburg Foundation

Marc Walﬁsh

The James and Debra Wallace

Foundation

Watkins Family Charitable Fund

WaWa, Inc.

Wechsler/Marsico Associates

The Harry & Jeanette Weinberg

Foundation, Inc.

Mr. Robert Weiss

The Western and Southern Life

Insurance Company

M&M Whitmire Family Foundation

Wichita Community Foundation

Mr. and Mrs. Jack Wilson

Mr. and Mrs. James F. and Judith

Watts Wilson

Wipe Out Leukemia Forever

Foundation, Inc.

Tom Woods Memorial Foundation

Wyeth Pharmeceuticals

Mrs. Dee Sanﬁlippo

Wyner Stokes Charitable Trust

Mark Zurack

Sponsors are institutions or

individuals that support a

Society event.

$100,000 – $499,999

American Airlines

American Bicycle Association

Bristol-Myers Squibb Company

Computer Associates

Disney Worldwide Services

Finish Line

Genentech

MCG Capital

Mercedes-Benz USA LLC

Motive, Inc.

Nike

Ortho Biotech

P.F. Chang’s China Bistro

PowerBar

Runner’s World

Seagate Technologies

Williams & Connolly LLP

$50,000 – $99,999

Mr. and Mrs. Melvin D. Booth

Comcast

Corixa

Cumberland Packing Corporation

Lawrence J. DeGeorge and Florence

A. DeGeorge Charit

Encounter Care Solutions, Inc.

Energy2Cure

Genentech BioOncology

GlaxoSmithKline

Hargrove, Inc.

IEP/MPG

Ms. Nancy S. Itteilag

Laborers’ Charitable Foundation

Lunardi’s Market

Michael McCarthy Foundation

Nemacolin Woodlands, Inc.,

84 Lumber Company & The Hardy

Family Trust

Nestle FoodServices

Nextel Communications, Inc.

The Sallie Mae Fund

Sunsail

SuperGen, Inc.

Toyota

West Marine

Western Asset Management

Windward Homes

Woodbine Entertainment Group

$10,000 – $49,999

20th Century Fox

Accenture

Acquest Development

ADC

AgVar Chemicals, Inc.

Akin, Gump, Strauss, Hauer

& Feld LLP

Alcalde & Fay

Mr. Pat Allender

Alston & Bird

AMDOCS

Amgen, Inc.

Anning-Johnson Company

Anonymous

Anteon International Corporation

AOR Management Company

Apache Corporation

Ariel Mutual Funds

Arizona Public Service

Arnold & Porter LLP

Aronson & Company

Mr. LaVar Arrington

ASI

AstraZeneca

AT&T

Aureus

BAE SYSTEMS

Bank of America

Banc of America Securities LLC

Bank of Tokyo-Mitsubishi

Barry Kaye & Associates

bcgi

BearingPoint, Inc.

Beers & Cutler

Berlex

Berlex Oncology

Bert Smith & Co.

Mr. and Mrs. Eric Billings

Biogen Idec

Blue Cross Blue Shield of Mississippi

Booz Allen Hamilton, Inc.

Borgata Heart and Soul Foundation

Bouchard Coastwise Management

Corporation

Bouchard Transportation Co., Inc.

Aaron Braun

Brayton Purcell

Bridgecom International

Mr. and Mrs. Peter and Janice Brock

Frank G. and Frieda K. Brotz Family

Foundation, Inc.

Brown Automotive Group

Buffalo Wild Wings

Cadell Dry Dock & Repair Co., Inc.

Calyon Financial, Inc.

Can-Am Contractors

Capital Automotive REIT

Capital One Services, Inc.

CapitalSource, Inc.

Cardservices International, Inc.

Ronald Carr Foundation

Carrella, Byrne, Bain, Gilﬁllan,

Cecchi, Stewart & Olstein

Carter’s

Carter BloodCare

Daniel S. Catalfumo Family

Foundation

CBRE CB Richard Ellis/L.J. Melody

Capital Markets

CB Richard Ellis – Corporation

Services

Celgene Corporation

Cell Therapeutics, Inc.

Centerplate NBSE

Chain Bridge Capital LLC

Chiron

CIBC World Markets

Crowe Chizek

Citigroup

Citizens Bank

The Cleveland Clinic Foundation

Clif Bar

Mr. Christopher Cline

Mr. George Cloutier

Kathy and Gary Coates

Cole Haan Wholesale

Comcast Cable

Compass Bank

Corporate Express Business Interiors

Costco

Countrywide Home Loans

The Crean Foundation

Credit Suisse First Boston

Mr. Ferdinand J. Crovato

Crowell & Moring LLP

Cruise Industry Charitable

Foundation

Cub Foods Bridgeview

Cub Foods Elston

Cub Foods Freeport

Cub Foods Joliet South

Cub Foods Regional Ofﬁce

2005 | ANNUAL REPORT

sponsor

partnerships

Danaher Corporation

DARCARS

Dave Walters Company

Dean Walters Companies

Decathlon Club

Degenstein Foundation

Delta Airlines

Deloitte

Mr. John Derose

Deutsche Bank

DEX

Dingbats & Abate Restaurants

Discovery Networks, U.S.

DLA Piper Rudnick Gray Cary

US LLP

Dominos

Dresser Flow Solutions

Duffy Mechanical Corporation

Duquesne Light

E*TRADE Financial

Easterns Automotive Group

EDS

EFW, Inc.

James L. Eichberg Foundation

Eli Lilly & Company

El Paso Corporate Foundation

Employees of FBR

Enterprise Rent-A-Car

Epsilon

Equifax, Inc.

Ernst & Young LLP

Ernst & Young LLP Transaction

Advisory Services

ESP-Pharma

Esprit Events, Inc.

FedEx Corporation

Fidelity National Title Agency

Figg Engineering Group

First Niagara Bank

Fisher Investments

FishHawk Ranch

Foodland Supermarkets

Samuel J. and Connie M. Frankino

Charitable Foundation

Fried, Frank, Harris, Shriver

& Jacobson

Mr. Emanuel J. Friedman

Friedman French Foundation

Future Tech Enterprises, Inc.

Gary Martin Hays and

Associates, PC

GEICO

General Dynamics

General Motors Corporation

Charles Gibbs, Jr.

Ms. Patricia Gioia

GMAC E.O. M & D

Goldman Sachs & Co.

Greenwich Capital Markets

Robert Gustafson

The Tom Merit Hancock Family Fund

Handleman Company

Paul Handlerly

A.L. Hanford Memorial Fund

Harkins Builders

Harris Private Bank

Hazmet Environmental

Hewitt Associates

Hewlett Packard

Highmark, Inc.

HITT Contracting, Inc.

Howard Capital Management, Inc.

an E*Trade Co.

Howard County General Hospital

Hy-Vee, Inc.

Ilex Oncology

Independence Air

Indianapolis Power & Light

Industrial Alliance Paciﬁce

Insulators Health Hazard Fund

The International Society

Jackson Lewis LLP

JFK Medical Center

Jim Koon’s Automotive Companies

JP Morgan Chase & Co.

Kaelin Family Captain’s Cup

Kaiser Permanente

Mr. and Mrs. Alexander L.

Karakozoff

K-Designers

Kekst & Company, Inc.

KPMG LLP

Kroger

KST Data, Inc.

Lakefront Communications, Inc.

LaSalle Bank

Lehman Brothers, Inc.

L.E.K. Consulting LLC

Linebarger, Goggan, Blair, Pena

& Sampson LLP

Lockton Companies

M&T Bank

Macy’s

Maguire Properties

Makar Management LLC

Manning Selvage & Lee

Manugistics, Inc.

Maryland State Council Knights

of Columbus

Masonite International Corporation

MCG Capital Corporation

MedImmune, Inc.

Medline Industries

Mellon Bank

Mercedes-Benz of Greenwich

Merrill Lynch & Co.

Microsoft Corporation

Mighty Taco

Millennium Pharmaceuticals, Inc.

Mills Limited Partnership

MK Real Estate Group, Inc.

Mr. and Mrs. Alfred T. Mockett

Mohegan Sun

Mondavi

Morris Levine Key Food Stores

Foundation, Inc.

Motorola

Mount Gay Rum

Munger, Tolles & Olsen

Mylan Charitable Foundation

National Commercial Flooring

National Cooperative Services

Corporation

National Rural Utilities Cooperative

Finance Corporation

National Trade Productions

Neiman Marcus

NeuStar, Inc.

NewMarket Corporation

New Quest Properties

Niello Company

Northrop Grumman

Novartis Oncology

Novartis Pharma Canada, Inc.

NVR, Inc.

Octagon

Oncology Therapeutics Network

Oracle Corporation

Ortho-Biotech

Owen Pharma

Panera Bread of Central Illinois

Parade

Paymentech

Peninsula Cancer Institute

PEPCO

Mr. Richard Perlman

Peterson Aluminum Corporation

Pﬁzer

PGA Tour Superstore

PGT Trucking, Inc.

Plumbers & Pipeﬁtters Local

Union 72

PNC Advisors

PPD Development LP

Prairie Farms

Prairie Meadows

Precision Communications

Price Modern

PricewaterhouseCoopers LLP

Protiviti

Pulse EFT Association

PVS Chemicals, Inc.

Dr. and Mrs. Richard Raizman

RBC Foundation

Realty Capital Partners

or Herndon LLC

Mr. Allen B. Rector

RE/MAX Harbor Realty

Reliable Churchill LLP

Mr. and Mrs. Bruce Rendina

Riverside Health System Foundation

Robert E. Torray & Company

Royal Bank of Scotland

Rural Telephone Finance Cooperative

Safeway

San Francisco Bay Area Labor

SAP

Satterﬁeld & Pontikes

SBC Communications, Inc.

Scheer Partners, Inc.

Schumacher Family Foundation, Inc.

Scotia Capital

Sewell Cadillac

Joseph Sheairs Associates, Inc.

Siemens

Silicon Valley Bank

Simpson Thacher & Bartlett LLP

SK Worldwide

Skyy Spirits LLC

Slawson Cunningham & Whalen PL

Slumberland

Smart Choice Settlements

Smith Barney Citigroup

Sony DADC

sponsor

partnerships continued

Southern California Edison

Mr. and Mrs. Mark Spisak

Sprint

St. Joseph’s/Candler

SteelFab

Stock Development LLC

Kilpatrick Stockton

StructureTone, Inc.

Sun Microsystems, Inc.

Sun Trust Banks, Inc.

Sun Trust Marine Lending

Systems Connection of Maryland

Target

Tech Village Partners LLC

Thelan, Reid & Priest LLP

Thompson, Habib & Denison

ThoughtWorks

Edgar A. Thronson Foundation, Inc.

Title, Inc.

Robert E. Torray & Company

Toyota

Turner Construction Company

Turner Interiors

UBS Investment Bank

UF & Shand’s Cancer Center

UNISYS

United Jewish Endowment Fund

University Hospital

University Hospitals Health System

Ireland Cancer Center

University of Pittsburgh Medical

Center

Versailles Ohio Poultry Days

Ultimate Frisbee Tournament

Virginia Mason Medical Center

Volvo of Savannah

Wachovia Corporation (First Union)

Wachovia Securities

Washington Building & Construction

Trades Council

Washington Express

Washington Gas

Washington Nationals

Washington Redskins Leadership

Council

Waste Management

Waterfront Properties, Inc.

Watson Wyatt Worldwide

WCI Communities

The Harry & Jeanette Weinberg

Foundation Incorporated

Weitz & Luxenberg PC

Wells Fargo

Westin Santa Clara

Wheeler Family Foundation

Mr. and Mrs. Stuart Williams

Williams & Connolly LLP

Wilmer, Cutler & Pickering Hale

and Dorr LLP

WIN WIN Strategies Foundation

WIVB-TV, Channel 4

Yellow Corporation

XM Satellite Radio

Promotions are individuals or

institutions that organize an event

and donate proceeds to the Society.

$1,000,000 and above

KGO Newstalk AM 810

$500,000 – $999,999

DialAmerica Marketing, Inc.

Verizon

$100,000 – $499,999

A&P/Super Fresh Supermarkets

ABC 7

Burlington Coat Factory

Computer Associates International,

Inc.

Cub Foods East

Equifax

The Olive Garden Italian Restaurant

Radio Disney AM 1110

Ruth’s Chris Steak House – Baltimore

Sports Radio 1130 WDFN

St. Valentine’s Day Luncheon and

Style Show

Team Friends of Allie – Honoring

Sam Eisenberg and Allie Scott

Windward Homes

WYAY EAGLE 106.7

$50,000 – $99,999

BIG 100.3

Booz Allen Hamilton

Clear Channel

CompUSA

Great American Insurance Company

$10,000 – $49,999

Airdrie Optimist Club

Arby’s

Austaco – Taco Bell

Bergstrom Automotive

Bowne & Co., Inc.

Luc and Maria Boisclair

– In Memory of Alex

Charter One Bank

The Classic Catering People

Coinstar

CWP Asset Corp. DBA Mister

Car Wash

Department 56

DEX

Dominos

Father Serra C.S.

Fox 5/UPN20

Freedom Valu Centers

Jack Moore Memorial Golf

Tournament

KTWV 94.7 The Wave

The McCormick Tribune Foundation

Media/Professional Insurance

Members 1st F.C.U.

Menkes Ltd. Developments

Mrs. Fields Cookies

Option One Mortgage

Randstad, North America

RBC Dominion Securities Inc.

The Regence Group

Ride of Dreams

S & T Enterprises, Inc.

San Par Leukemia Beneﬁt

Sheraton Gateway

Shula’s, Inc.

The Susquehanna Ski

and Snowboard Club

Vibro-Acoustics

Volvo of Mississauga

Waddell & Reed

Washington Business Journal

WIVB-TV, Channel 4

Wisconsin Public Service

National Man & Woman of the Year

Jim Morrison

Lizzy Walker Conroy

2005 | ANNUAL REPORT

promotion

partnerships

The Legacy Circle honors those

who have included the Society

in an estate plan.

Hugh Albora

Peter Alexas

Bruce Allen

Fay Allen

Margaret H. Anderson

Marjorie Anderson

Debra Andrade

Mr. and Mrs. David Andrews

James and Eileen Andrews

Kristi Anys

Estate of Louise K. Archer

Lucy Attner

Lorae P. Aumack

Minnie Austin

Mr. and Mrs. Jay Barrows

John Bashta

Mr. and Mrs. Edwin J. Beckley, Jr.

Angelo Bardi

Ruth Bartlett

Claudia and Stephen Barto, Jr.

Margaret Beers

Dennis Beardsley

Ryan Beagin

Steven R. Bender

Ami Berkowitz

Clyde S. and Rosie Billman

Alexandra Mayes Birnbaum

The Stephen Birnbaum Foundation

Margaret Black

Richard Blond

Christopher Blum *

Lori Blum

Sally Blume

Robert H. and Janet Bohannon

James Bolton

Mart Bort

William Boyd

Irvin B. Braverman, MD

Wilburn Brewer, Jr. *

Judith Arner Brown

Richard Cahill

Scott A. Carroll

Jennifer Caves

Mary Carver

Colon B. Carter

Robert Charon

Pasquale R. Cheche

Thomas Cheek

David E. Cherry

Christina Clapham

Sylvia Clemetson

Paul and Nancy Clendening

Denise Coats

Wayne Cope

Michael and Liz Copley

Michelle Cromwell

Katherine Wageman-Cook

Dr. Anthony Cortese

Marianne Cotter

Raymond Cox

Steve R. Craig and Susan Laine

Marilyn J. Crohan

Lydia D’Agosto

Edmund D’Allesio

Judy Davis

Robert D. Dean

Dr. and Mrs. Michael L. Dean

Carolyn Dee

David and Connie Dimling

Kathy Dirckx

Dorothy Dootson

Joel Drake

Harry and Barbara Dunlap

John Dunn

Timothy S. Durst

Agnes Dury

George F. and Evelyn Eckhardt, Jr.

Clif Edwards

J. Stephen Eickert

Greg Elfers

Mr. and Mrs. Jeffrey Ellena

Judith Erickson

Dr. George A. Farber, Sr.

Lynne E. Fazzi

Arnold Feldman

Harold Fennell

Harvey Fernbach, MD

Richard Fess

Helen F. Fisher *

Deidre Fitzpatrick

Thomas L. Fitzpatrick

The Honorable Ronald A. Fonseca

Charles and Evelyn Foster

Mr. and Mrs. James T. Fox

Leo Frank

David Frantze

Jon Freitag

Paul N. Frimmer

Roberta Fuhr

Albert and Gladys Gardner

Marian Genarro

Anna Maria Gentile

John A. Geoghegan

Richard and Jacqueline Geswell

Patricia Ghiglieri

Douglas Gilbert

Noreen L. Giese

Heather Girard

Wade Goehring

Jacob and Sara Gold

Richard Goldberg

Wilma Gottlieb

Miss Barbara Grace

Rebecca Ann Grajewski

Ruth Granat *

Carol Grandaw

Mr. and Mrs. Forrest Grosvenor

Dan and LaDonna Gubitz

Carter K. D. Guice, Jr.

John Haluck

Mr. and Mrs. Ken Haller

Liliana Hamilton

Keith P. Harenda

Joan Haratani

Alice Hatch

Pat Hauer

Kathleen Hays, RN, MSN

Donald P. Heim

Tom and Wendy Henry

Dr. Saul Highman

Catherine E. Hildreth

Leila Hittinger

C. Brooks Hoffman

William Hoffman

Carol Hogan

Fay Holzman

Courtney and Robin Hollar

Mr. and Mrs. Steven Hooker

Jacqueline Hood

Jeanie Hoover *

Lynn C. Hoover

Beth Hoth

John Harrison Hough

Roy Hovinen

Dwayne Howell

Barbara Hufford

Heather Hunt

Dr. Brian Hurley

William Ianniello

Charles F. Ingleﬁeld

Deborah Jaskulski

Mrs. Lily Marie Jeffreys

Anne K. Johnson

Harry and Donna Johnson III

Kristen Johnson

Mrs. Darden Jones

Dan and Leslie Jordanger

John and Judith Kamins

Patricia Kay

Nathan and Ruthie T. Katz

Michael E. Keefe

Mr. and Mrs. Christopher J. Kearns

John B. Kelly

Michael Kerper

Frances Keating

Annabelle King, MD

Sue Kinney-Wieland

T. Corey Kipp

Monica Klapper

Susan Kobrel

Karl Koepke

Jeff and Teresa Kopietz

Carmella Kramer

Mark and Christine Kraemer

Leslie Elliot Krause, Esq.

Marjo Kremko

R. Scott Krizek

Mr. and Mrs. Greg Kulm

Janna LaCock

Janet LaVere

John Lamb, Jr.

Lucy Lang

Alan P. Laskin

William S. Lear

Diana Lynn Lee

Gail M. Lee

Joseph Lee

Kelli Lefﬁngwell

Lon Leneve

Paul L. Lewis

Robert Lindsey

Harvey and Linda Litofsky

Geoffrey Lombard

the legacy circle

Mr. and Mrs. F. F. Michael Lynch

Eric and Becky Mahlum

Ida Malena

Georgia Davidis Malone

Maria Maramag

Dr. and Mrs. Stanley N. Marks

Greg Martin

William Martin

Mark E. Mason

Joan Maves

Robert and Marnee Maylone

Rita Meek, MD

Rhonda Meeks

Timothy and Susan Metzer

John and Patty McDonald

Thomas and Olive McDonald

Dorothy McCann

Marilyn McFadden

Sylvia McGovern

Carolyn E. McKown

Mr. and Mrs. Clayton McPhail

Anthony McPherson

Lisa A. Mihalik

Paul Hart Miller

Tina Marie Milligan

Suzy Minkoff

Joshua Mitchell, MD

Ted Mociun

Michael and Tammy Moloy

Dennis F. Moore, MD

Joann Moran

Mr. and Mrs. Thaddee F. Moreau

Dennis Morris

James Morton

Robert J. Moyle

Frank Mungo

Suzanne J. Muntzing

Oscar Muskopf

Rodman N. Myers

Robert J. Myette

The Honorable Robert H. Newman

Tracy Newman

Robert C. Niles

Regina Nizzoli

Edward Nofer III

Jason North

Richard F. Nourie

Jeanne Null

Carolyn and Jerry O’Hara

Edward D. O’Malley

Mrs. Harry O’Toole

Margaret Olmazu

George Omiros

Rosemary Opbroek

Mary J. Oyer

Jacqueline Anne Palmenberg

Frederic and Wannelle Parvey

Rosa Pena

Stephen M. Peters

Mr. and Mrs. David L.Pfeiﬂe

Leslea S. Pidgeon

William Pike

Lisa Pirrung

Ginette Poitevent

George Pooley *

Mr. and Mrs. Chris Post

Leila Elizabeth Presniak

Mr. and Mrs. Michael Price

Larry Pyles

David B. and Toni Quinty

Marty Rauch

Diane Raymond

Richard and Kathy Reader

Helen Doss Reed

Larry E. Reinart

Ernestine Reinert

James Relkin

David Rice *

Marilyn Richardson

Joseph Russell

Donald G. Rigoni

Ernest Riise

Gary and Becky Roberts

Judith A. Ross

Mrs. Syril Rubin

Seth and Carolyn Rudnick

Kevin R. Ryan

Victor and Jacqueline Sacco

William H. Sachs

Robert M. Sanders

Dee Sanﬁlippo

Thomas J. Scanlon

David and Barbara Schaefer

Karl Schaeffer

Ken Scherzer

Patrick Schmidt

Eugene Schmitt *

Deborah Scott-Ensley

Lorraine Seidel

David A. Schick

Maya B. Shenoy

Norman and Katrine Shorb

Frank T. Short

Frank Sidwell

Norbert J. Sieber

Jay and Elaine Silver

Linda Sims

Tena Simmons

Irene Skomro

Rose Slotsky

Mary-Gail Smith

Mr. and Mrs. Robert Smith

Russell D. Smith

Nicoma Sobolewski

Jeffrey and Angela Solomonson

John C. Sorrell

Elda Spano

James E. Sparkes

Barbara A. Spiegel

Thomas and Joanne Spink

Mark and Carol Spisak

Darrin Sprilczuk *

Carole Stadﬁeld

Inez Star

Richard Steffen

Fred and Simone Stella

Paula and Phillip Stone

Brian J. Stumm

Marcie Summerlin

Dolores Swirin

Merideth Tall

Stewart Teichman

Gracie Thompson

Patricia Trosclair

Joe and Lorraine Tumolo

Heather Turnbull

Paul and Debra Vaughn

Joseph and Karen Verdirame

Bert Vignes

Laura Walker

Mr. and Mrs. Rubin Wallach

Michael Walrath *

Michael E. Walsh

Dr. Robin Walsh

John E. Walter

Kimberly Walton

Phyllis J. Walton

Dr. Vicque L. Walton-Kimmel

Beverly G. Warner

Louise Warner

Philip F. Warner

Paul Weiden, MD

Phyllis Weil

Deborah Weinstein

James A. Weinberg

Paul and Annie Weiss

W. Russell Welsh

Mr. and Mrs. John Wempe

Steven Wescoatt

Larry and Kathleen Wheaton

Dr. and Mrs. Stanley A. White

Carl and Hillary Whitley

Don Wier

Stephen and Terri Williams

Anthony and Michelle Wong

Clara Wood

Laura B. Worsham

Mr. and Mrs. Douglas Young

Joseph Yurfest

Ed Yurowksi

Violet Yurowski *

Thomas and Anne Zak

Mr. and Mrs. Scott Zeilinger

Katherine Zell-Cherry

Mrs. Ruth Zyskowski

2005 | ANNUAL REPORT

the legacy circle continued

Anonymous (224)

Members as of June 30, 2005

* Deceased

independent auditors’

report

The Board of Directors

The Leukemia & Lymphoma Society, Inc.:

We have audited the accompanying consolidated statement of ﬁnancial position of The Leukemia

& Lymphoma Society, Inc. (the Society) as of June 30, 2005, and the related consolidated

statements of activities, cash ﬂows, and functional expenses for the year then ended. These

consolidated ﬁnancial statements are the responsibility of the Society’s management. Our

responsibility is to express an opinion on these consolidated ﬁnancial statements based on our

audit. The prior year summarized comparative information has been derived from the Society’s

2004 consolidated ﬁnancial statements and, in our report dated October 1, 2004, we expressed

an unqualiﬁed opinion on those statements.

We conducted our audit in accordance with auditing standards generally accepted in the United

States of America. Those standards require that we plan and perform the audit to obtain

reasonable assurance about whether the ﬁnancial statements are free of material misstatement.

Our audit included consideration of internal control over ﬁnancial reporting as a basis for

designing audit procedures that are appropriate in the circumstances, but not for the purpose

of expressing an opinion on the effectiveness of the Society’s internal control over ﬁnancial

reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis,

evidence supporting the amounts and disclosures in the ﬁnancial statements. An audit also

includes assessing the accounting principles used and signiﬁcant estimates made by management,

as well as evaluating the overall ﬁnancial statement presentation. We believe that our audit

provides a reasonable basis for our opinion.

In our opinion, the consolidated ﬁnancial statements referred to above present fairly, in all

material respects, the ﬁnancial position of The Leukemia & Lymphoma Society, Inc. as

of June 30, 2005, and the changes in its net assets and its cash ﬂows for the year then ended

in conformity with accounting principles generally accepted in the United States of America.

September 30, 2005

New York, NY

2005 | ANNUAL REPORT

2005 2004

Assets

Cash and cash equivalents $ 6,116 $ 22,703

Accounts receivable 672 555

Legacies and contributions receivable (note 2) 5,026 5,347

Prepaid expenses 4,246 4,024

Investments, at fair value (note 3) 131,770 83,653

Fixed assets, less accumulated depreciation

and amortization of $7,594 and $6,289 4,098 3,624

Total assets $ 151,928 $ 119,906

Liabilities and Net Assets

Liabilities:

Accounts payable and accrued expenses $ 17,667 $ 13,039

Deferred revenue 10,755 6,795

Grants payable (note 4) 56,774 46,613

Total liabilities 85,196 66,447

Net assets:

Unrestricted 59,574 46,674

Temporarily restricted (note 7) 4,495 4,465

Permanently restricted (note 7) 2,663 2,320

Total net assets 66,732 53,459

Total liabilities and net assets $ 151,928 $ 119,906

consolidated statement of financial position

The Leukemia & Lymphoma Society, Inc.

June 30, 2005

(with comparative amounts at June 30, 2004)

(in thousands)

See accompanying notes to consolidated ﬁnancial statements.

Temporarily Permanently Total

Unrestricted Restricted Restricted 2005 2004

Revenue

Campaign contributions $ 225,380 $ 10,782 $ – $ 236,162 $ 201,104

Less direct donor beneﬁt costs (32,620) – – (32,620) (28,394)

Net campaign contributions 192,760 10,782 – 203,542 172,710

Legacies 4,599 72 89 4,760 2,462

Donated services (note 1) 4,205 – – 4,205 –

Net interest and dividend income (note 3) 2,632 65 – 2,697 841

Net increase (decrease) in fair value of investments 2,711 (18) 15 2,708 3,256

Grant refunds 653 – – 653 881

Net assets released from restrictions 10,999 (10,999) – – –

Total revenue 218,559 (98) 104 218,565 180,150

Expenses (note 8)

Program Services:

Research 54,037 – – 54,037 42,899

Patient and community service 58,821 – – 58,821 46,603

Public health education 32,598 – – 32,598 28,540

Professional education 9,846 – – 9,846 9,071

Total program services 155,302 – – 155,302 127,113

Supporting Services:

Management and general 16,225 – – 16,225 14,048

Fund raising 35,161 – – 35,161 30,508

Total supporting services 51,386 – – 51,386 44,556

Total expenses 206,688 – – 206,688 171,669

Excess (deﬁciency) of revenue over expenses 11,871 (98) 104 11,877 8,481

The Leukemia & Lymphoma Society of Canada

(“LLSC”) net assets as of July 1, 2004 (note 1) 1,029 128 239 1,396 –

Change in net assets 12,900 30 343 13,273 8,481

Net Assets

Beginning of year 46,674 4,465 2,320 53,459 44,978

End of year $ 59,574 $ 4,495 $ 2,663 $ 66,732 $ 53,459

consolidated statement of activities

The Leukemia & Lymphoma Society, Inc.

Year ended June 30, 2005

(with summarized totals for the year ended June 30, 2004)

(in thousands)

See accompanying notes to consolidated ﬁnancial statements.

2005 | ANNUAL REPORT

2005 2004

Cash flows from operating activities:

Change in net assets $ 13,273 $ 8,481

Adjustments to reconcile change in net assets to

net cash provided by operating activities:

Net assets of LLSC at merger (1,396) –

Net increase in fair value of investments (2,708) (3,256)

Permanently restricted revenue collected (89) (928)

Depreciation and amortization 1,186 1,209

Changes in assets and liabilities:

Increase in accounts receivable (78) (173)

Decrease in legacies and contributions receivable 321 1,726

Increase in prepaid expenses (197) (587)

Increase (decrease) in accounts payable and accrued expenses 4,520 (251)

Increase in deferred revenue 3,848 1,504

Increase in grants payable 9,325 2,911

Net cash provided by operating activities 28,005 10,636

Cash flows from investing activities:

Purchases of ﬁxed asstes (1,244) (937)

Purchases of investments (202,996) (70,733)

Sales of investments 158,310 51,115

Net cash used in investing activities (45,930) (20,555)

Cash flows from financing activities:

LLSC cash at merger 1,249 –

Permanently restricted revenue collected 89 928

Net cash provided by ﬁnancing activities 1,338 928

Net decrease in cash and cash equivalents (16,587) (8,991)

Cash and cash equivalents at beginning of year 22,703 31,694

Cash and cash equivalents at end of year $ 6,116 $ 22,703

consolidated statement of cash flows

The Leukemia & Lymphoma Society, Inc.

Year ended June 30, 2005

(with comparative amounts for the year ended June 30, 2004)

(in thousands)

See accompanying notes to consolidated ﬁnancial statements.

Program Services Supporting Services

Patient and Public Management Direct donor

community health Professional and Fund Total benefit costs

Research service education education Total general raising Total 2005 2004 2005 2004

Awards and grants $51,310 $ – $ – $ – $51,310 $ – $ – $ – $51,310 $41,084 $ – $ –

Financial aid to patients – 4,505 – – 4,505 – – – 4,505 4,020 – –

Donated services 533 3,672 – – 4,205 – – – 4,205 – – –

Salaries 557 23,277 10,749 4,396 38,979 5,964 7,881 13,845 52,824 43,612 – –

Employee beneﬁts and taxes (note 5) 99 4,903 2,660 1,057 8,719 1,345 2,132 3,477 12,196 10,583 – –

Occupancy 22 2,684 1,524 638 4,868 793 1,117 1,910 6,778 6,423 – –

Insurance 10 243 167 52 472 73 162 235 707 650 – –

Telephone 17 1,059 745 167 1,988 232 1,144 1,376 3,364 3,079 – –

Travel 26 1,052 574 243 1,895 332 413 745 2,640 2,100 11,760 10,859

Printing and supplies 196 4,345 5,835 877 11,253 2,523 7,704 10,227 21,480 20,428 5,758 5,070

Equipment rentals and maintenance 14 811 474 188 1,487 239 387 626 2,113 1,841 – –

Postage and shipping 75 2,336 3,756 541 6,708 1,218 5,578 6,796 13,504 11,993 – –

Meetings 591 1,762 852 323 3,528 408 531 939 4,467 3,492 7,331 5,906

Professional fees 560 7,316 4,750 1,166 13,792 2,798 7,683 10,481 24,273 19,978 3,608 2,945

Miscellaneous 12 441 234 107 794 174 168 342 1,136 1,177 4,163 3,614

Depreciation and amortization 15 415 278 91 799 126 261 387 1,186 1,209 – –

Total expenses

$ 54,037 $ 58,821 $ 32,598 $ 9,846 $

155,302

$ 16,225 $ 35,161 $ 51,386 $206,688 $171,669 $ 32,620 $ 28,394

Direct donor

Total benefit costs

consolidated statement of functional expenses

The Leukemia & Lymphoma Society, Inc.

Year ended June 30, 2005

(with comparative totals for the year ended June 30, 2004)

(in thousands)

Research 34.8%

program services expenses

37.9%

27.3%

34.8%

Patient and Community Service 37.9%

Public Health and Professional Education 27.3%

2005 | ANNUAL REPORT

1. Organization and Signiﬁcant Accounting Policies

Organization

The Leukemia & Lymphoma Society, Inc. (the “Society”) is

an international not-for-proﬁt health agency dedicated to seeking

the cause and cure of leukemia, lymphoma, Hodgkin’s disease

and myeloma and improving the quality of life of patients and

their families. The Society’s principal activities include: awarding

research grants; facilitating psychosocial support groups; providing

ﬁnancial aid to patients; answering phone requests for blood-

related cancer information made to the Society’s Information

Resource Center; and disseminating educational information

about blood-related cancers in the form of publications, internet

sites, conference calls and symposia sponsorship for both the

medical community and the general public.

The Society entered into a merger agreement with Leukemia

Research Fund of Canada (“LRFC”), effective July 1, 2004, under

which the Society has approval rights over all LRFC resolutions.

As part of this agreement, the name of LRFC was changed

to The Leukemia & Lymphoma Society of Canada, Inc. (“LLSC”).

The merger was accounted for in accordance with purchase

method concepts whereby a contribution of LLSC’s net assets

(at fair value) was recorded by the Society.

Tax-Exempt Status

The Society qualiﬁes as a charitable organization as deﬁned

by Internal Revenue Code Section 501(c)(3) and, accordingly,

is exempt from federal income taxes under Internal Revenue

Code Section 501(a). Additionally, since the Society is publicly-

supported, contributions to the Society qualify for the maximum

charitable contribution deduction under the Internal Revenue

Code.

LLSC is registered as a charitable organization under the Income

Tax Act (Canada) and is therefore not subject to income taxes

if certain disbursement requirements are met.

Principles of Consolidation

The accompanying consolidated ﬁnancial statements include

the accounts of the Society, which encompasses the Home Ofﬁce

of the Society and its sixty three chapters, LLSC, and the Society’s

not-for-proﬁt afﬁliates, The Leukemia & Lymphoma Society

Research Programs, Inc. and The Leukemia & Lymphoma

Society Research Foundation. All signiﬁcant inter-company

and intra-Society accounts and transactions have been eliminated

in consolidation.

Net Asset Classiﬁcations

To ensure observance of limitations and restrictions placed on

the use of resources available to the Society, funds that have

similar characteristics have been classiﬁed into three net asset

categories as follows:

Unrestricted net assets: Consist of funds that are fully

available, at the discretion of the Board of Directors, for the

Society to utilize in any of its programs or supporting services.

Temporarily restricted net assets: Consist of funds that are

restricted by donors for a speciﬁc time period or purpose, as

well as amounts relating to term endowment or deferred giving

arrangements in which the funds must be maintained intact

over the lifetimes of the donors.

Permanently restricted net assets: Consist of funds that

contain donor-imposed restrictions requiring that the

principal be invested in perpetuity and that only the income

be used. Income earned on these funds may be unrestricted

or temporarily restricted, depending upon the donor-imposed

restrictions.

Contributions and Deferred Revenue

Contributions are recorded as revenue, at their fair value,

when received or promised unconditionally. Contributions

received with donor restrictions that limit their use are reported

as either temporarily or permanently restricted revenue.

When a donor restriction is met through the passage of time

or fulﬁllment of a purpose restriction, temporarily restricted

net assets are reclassiﬁed to unrestricted net assets and reported

in the statement of activities as net assets released from

restrictions. Conditional contributions are recognized as

revenue when the conditions have been substantially met.

Deferred revenue includes amounts received for special events

that will be held subsequent to the ﬁscal year-end.

Donated Services

In 2005, the Society determined that certain of the donated

services it received met the criteria for recognition in the ﬁnancial

statements. Speciﬁcally, the donated services of family support

group facilitators and research grant reviewers have been valued

and are reported as both revenue and expense in 2005. Since

there is no impact on the reported change in net assets, the

Society has not retroactively recorded these donated services in

2004. Society management believes the value of donated services

in 2004 was comparable to that in 2005.

Cash Equivalents

Cash equivalents consist of short-term investments with

a maturity of three months or less from date of purchase, except

for amounts held for long-term purposes reported as investments.

Fixed Assets and Depreciation

Fixed assets, which consist principally of equipment and

leasehold improvements, are recorded at cost, if purchased, or at

fair value at date of donation, if contributed, and are depreciated

or amortized using the straight-line method over the estimated

useful lives of the assets or the terms of the leases, if shorter.

Estimates

The preparation of ﬁnancial statements in conformity with

generally accepted accounting principles requires the Society’s

management to make estimates and assumptions that affect the

amounts reported in the ﬁnancial statements and accompanying

notes. Actual results could differ from those estimates.

Summarized Financial Information

The ﬁnancial statements are presented with 2004 summarized

or comparative information. With respect to the statement

of activities, such prior year information is not presented by net

assets class and, in the statement of functional expenses, 2004

expenses by object are presented in total rather than by functional

category. Accordingly, such information should be read in

conjunction with the Society’s 2004 consolidated ﬁnancial

statements from which the summarized information was derived.

notes to consolidated financial statements

The Leukemia & Lymphoma Society, Inc.

Year ended June 30, 2005

(with comparative amounts as of and for the year ended June 30, 2004)

2. Legacies and Contributions Receivable

The Society’s legacies and contributions receivable at June 30, 2005

and 2004 consist of unconditional promises to give and legacies

for which the underlying wills have been declared valid by the

probate court and no other conditions are required to be met.

Amounts are scheduled to be received as follows (in thousands):

2005 2004

Less than one year $ 4,795 $ 5,020

1 to 5 years 256 351

5,051 5,371

Less discount to present value

(discount rate – 5%) (25) (24)

Total $ 5,026 $ 5,347

3. Investments

The following is a summary of investments at June 30, 2005 and

2004 (in thousands):

2005 2004

Cost or Cost or

Donated Fair Donated Fair

Value Value Value Value

Money market funds $ 48,876 $ 48,876 $ 24,874 $ 24,874

Corporate notes and bonds 19,421 19,466 12,999 13,027

Common stocks and mutual funds 28,251 30,779 26,853 28,310

U.S. Government obligations 27,605 27,698 17,383 17,384

Other 4,771 4,951 58 58

Total $128,924 $131,770 $ 82,167 $ 83,653

Debt and equity securities are recorded at fair value as determined

by quoted market prices. Mutual funds are recorded at fair value

using published unit values. Investment expenses of $284,000 and

$281,000 have been netted against interest and dividend income

for the years ended June 30, 2005 and 2004, respectively.

4. Awards and Grants

Awards and grants for research are recognized as expense

in the year approved by the Society’s Board of Directors.

Multi-year grants, which are generally two to ﬁve years in length,

are approved on an annual basis and may be terminated at the

discretion of the Society’s Board of Directors. In addition to

unconditional grants payable of $56,774,000 at June 30, 2005,

the Society has grant commitments of $90,345,000 that are

conditioned upon future events and, accordingly, are not

recorded.

5. Pension Plan

The Society has a noncontributory, deﬁned contribution 403(b)

pension plan covering all employees meeting age and service

requirements. Contributions are based on a percentage of each

eligible employee’s salary and years of service. Expense under this

plan aggregated $2,327,000 and $2,194,000 for the years ended

June 30, 2005 and 2004, respectively.

6. Lease Commitments

The leases for premises which the Society’s Home Ofﬁce and

chapters occupy expire on various dates through December 31,

2012 and provide for certain payments subject to escalation

and periodic rate increases relating to real estate taxes, operating

expenses and utilities.

The approximate minimum future annual rental commitments

are summarized as follows (in thousands):

Year ended June 30:

2006 $ 6,146

2007 5,722

2008 5,122

2009 4,427

2010 4,527

Thereafter 1,535

Total $ 27,479

7. Temporarily and Permanently Restricted Net Assets

Temporarily restricted net assets and the income earned on

permanently restricted net assets are available for the following

purposes at June 30, 2005 and 2004 in thousands):

2005 2004

Temporarily Permanently Temporarily Permanently

Restricted Restricted Restricted Restricted

Research program $ 2,810 $ 2,616 $ 3,578 $ 2,273

Patient service and

bone marrow donor programs 255 – 215 –

Professional education program 24 47 23 47

Other programs 1,406 – 649 –

Total $ 4,495 $ 2,663 $ 4,465 $ 2,320

8. Joint Costs Allocation

In 2005 and 2004, the Society incurred joint costs for informational

materials and activities that included fund raising appeals as follows

(in thousands):

2005 2004

Fund raising $ 14,166 $ 12,225

Patient and community service 1,612 1,446

Public health education 8,616 7,675

Total $ 24,394 $ 21,346

notes to consolidated financial statements

2005 | ANNUAL REPORT

Chairman of the Board

John M. Kamins

Honigman Miller Schwartz and Cohn

Detroit, MI

Vice Chairman for Medical and

Scientiﬁc Affairs

Beverly S. Mitchell, MD

Cancer Research Center

Stanford University

Stanford, CA

Vice Chairman for Field Relations

David Frantze

Stinson, Mag & Fizzell, PC

Kansas City, MO

Vice Chairman for Patient Services

Marie Lauria, MSW

Chapel Hill, NC

Vice Chairman for Resource

Development

Margaret H. Anderson

Anderson, Bryant, Lasky

& Winslow, PSC

Louisville, KY

Secretary/Treasurer

Thomas L. Fitzpatrick

Saint Gobain Corporation

Worcester, MA

Board of Directors

Alexandra Mayes Birnbaum

Peartree Communications, Inc.

New York, NY

Robert A. “Spider” Cantley

Twainharte, CA

Paul J. Cienki

General Dynamics Network Systems

Needham, MA

Michael Copley

Children’s Hospital & Health Center

San Diego, CA

Lawrence D. Ellis, MD

University of Pittsburgh

Pittsburgh, PA

Paul N. Frimmer

Irell & Manella, LLP

Los Angeles, CA

John A. Geoghegan

Gellert & Quartararo, PC

Purchase, NY

Alan M. Gewirtz, MD

University of Pennsylvania

School of Medicine

Philadelphia, PA

Carter K. D. Guice, Jr.

Eastern District of Louisiana

New Orleans, LA

Steven L. Hooker

The Regence Group

Portland, OR

Lynn C. Hoover

Stinson Morrison Hecker, LLP

Kansas City, MO

Thomas F. Hunter

Stimulys

Carrollton, TX

Charles F. Ingleﬁeld

Bay Village, OH

John B. Kelly

Capitol Financial Group

Sacramento, CA

Leslie Elliot Krause, Esq.

Law Ofﬁces of Leslie Elliot Krause

New York, NY

Michael W. Long, PhD

Velcura Therapeutics, Inc.

Ann Arbor, MI

Dennis F. Marco

North Haledon, NJ

W. Stratford May, Jr., MD, PhD

University of Florida

Gainesville, FL

Thomas R. McDonald

Marana, AZ

Richard H. Michalik

Naperville, IL

Rodman N. Myers

Honigman Miller Schwartz and Cohn

Detroit, MI

Jason North

JSN Consulting

Palm Beach, FL

Mary J. Oyer

Northﬁeld, IL

Frederic C. Parvey

Fidelity National Financial

Jacksonville, FL

William H. Reimers

Bowman Enterprises, Inc.

Raleigh, NC

Marcie Rehmar Rogell

Children’s Hospital

Columbus, OH

Naomi Rosenberg, PhD

Tufts University School of Medicine

Boston, MA

Kevin R. Ryan

Yampolsky, Mandeloff, Silver & Co.

Philadelphia, PA

Maya B. Shenoy

Charlotte, NC

Frank T. Short

Short Strategy Group, Inc.

Indianapolis, IN

Norbert J. Sieber

MARC USA

Miami, FL

Jay L. Silver

Sugar Land, TX

Thomas R. Snyder

Nashville Bank and Trust

Nashville, TN

James E. Sparkes

Sugarman Law Firm, LLP

Syracuse, NY

James J. Stephanak

The Kalamazoo Gazette

Kalamazoo, MI

William M. Ward, Jr.

Presbyterian Manors of Mid-America

Wichita, KS

Robert M. Yacobi

Williamsburg, VA

national leaders

Ofﬁcers

Harry Pearce

•

President

Of Counsel

Bowman and Brooke

John M. Kamins

•

Vice President

Partner

Honigman Miller Schwartz and Cohn

Beverly S. Mitchell, MD

•

Medical Vice President

Cancer Research Center

Stanford University

Dwayne Howell

•

Secretary-Treasurer

President & Chief Executive Ofﬁcer

The Leukemia & Lymphoma Society

Members

Alexandra Mayes Birnbaum

Peartree Communications, Inc.

Tom Bertelsen

Dominican Sisters of San Rafael

Andrew Madoff

Bernard L. Madoff Investment

Securities

Scott Zeilinger

Kadima Partners, LLC

Medical Advisory Board

Edward J. Benz, Jr., MD

President

Dana-Farber Cancer Institute

Donald Pinkel, MD

San Luis Obis Co., CA

Louis W. Sullivan, MD

President

Morehouse School of Medicine

E. Donnall Thomas, MD

Fred Hutchinson Cancer

Research Center

Professor of Medicine, Emeritus

University of Washington

School of Medicine

the leukemia & lymphoma society

research foundation

Dwayne Howell

President & Chief Executive Ofﬁcer

Laurence W. Hausner

Chief Operations Ofﬁcer

Field Management

Cynthia Gardner

Executive Vice President

Field Management

Paul Weiss

Senior Vice President

Field Management

Leslie Chambers

Senior Vice President

Field Management

Finance, Administration

& Information Technology

John E. Walter

Executive Vice President

& Chief Financial Ofﬁcer

Finance, Administration

& Information Technology

Jimmy Nangle

Senior Vice President

Finance

Jon R. Lowell

Chief Information Ofﬁcer

Government & Legislative Affairs

George Dahlman

Vice President

Public Policy

Human Resources Development

Beverly Sherbondy

Senior Vice President

Human Resources

Marketing Communications

& Revenue Development

Richard J. Geswell

Executive Vice President

Revenue & Marketing

Nancy Klein

Senior Vice President

Marketing Communications

Greg Elfers

Senior Vice President

Campaign Development

Patient Services

Robin Kornhaber, MSW

Senior Vice President

Patient Services

Research & Medical Programs

Marshall A. Lichtman, MD

Executive Vice President

Research & Medical Programs

Louis DeGennaro, PhD

Senior Vice President

Research Administration

The Leukemia & Lymphoma

Society of Canada

Rudy Putns

Chief Executive Ofﬁcer

senior staff

Alabama

Gulf Coast Chapter

100 Chase Park South • Suite 220

Birmingham, AL 35244

Telephone: 205.989.0098

Arizona

Desert Mountain States Chapter

3877 North 7th Street

•

Suite 300

Phoenix, AZ 85014

Telephone: 602.788.8622

California

Central California Chapter

470 East Herndon

•

Suite 102

Fresno, CA 93720-2929

Telephone: 559.435.1482

Greater Los Angeles Chapter

6033 West Century Boulevard

•

Suite 300

Los Angeles, CA 90045

Telephone: 310.216.7600

Greater Sacramento Area Chapter

4604 Roseville Road

•

Suite 100

North Highlands, CA 95660

Telephone: 916.348.1793

Greater San Francisco Bay Area Chapter

1390 Market Street

•

Suite 1200

San Francisco, CA 94102-5306

Telephone: 415.625.1100

Northern California Division

1390 Market Street

•

Suite 1200

San Francisco, CA 94102-5306

Telephone: 415.625.1100

Orange County Inland Empire Chapter

2020 East First Street

•

Suite 120

Santa Ana, CA 92705

Telephone: 714.881.0610

San Diego/Hawaii Chapter

8575 Gibbs Drive

•

Suite 26.2

San Diego, CA 92123

Telephone: 858.277.1800

Silicon Valley & Monterey Bay Area Chapter

675 North First Street

•

Suite 1100

San Jose, CA 95112-5155

Telephone: 408.271.2873

Southern California Division

6033 West Century Boulevard

•

Suite 300

Los Angeles, CA 90045

Telephone: 310.216.7600

Colorado

Rocky Mountain Chapter

5353 West Dartmouth Avenue

Denver, CO 80227

Telephone: 303.984.2110

Connecticut

Connecticut Chapter

300 Research Parkway

•

Suite 310

Meriden, CT 06450

Telephone: 203.379.0445 or 888.282.9464

Fairﬁeld County CT Chapter

25 Third Street

•

4th Floor

Stamford, CT 06905

Telephone: 203.967.8326

Delaware

Delaware Chapter

100 West 10th Street

•

Suite 209

Wilmington, DE 19801

Telephone: 302.661.7300

Florida

Central Florida Chapter

3319 Maguire Boulevard

•

Suite 101

Orlando, FL 32803

Telephone: 407.898.0733

Northern Florida Chapter

7077 Bonneval Road

•

Suite 610

Jacksonville, FL 32216

Telephone: 904.332.6414

Palm Beach Chapter

4360 Northlake Boulevard

•

Suite 109

Palm Beach Gardens, FL 33410

Telephone: 561.775.9954

Southern Florida Chapter

3325 Hollywood Boulevard

•

Suite 400

Hollywood, FL 33021

Telephone: 954.961.3234

Suncoast Chapter

13907 North Dale Mabry Highway

•

Suite 101

Tampa, FL 33618

Telephone: 813.963.6461

Georgia

Georgia Chapter

2625 Cumberland Parkway

•

Suite 205

Atlanta, GA 30339

Telephone: 770.438.6006

Illinois

Illinois Chapter

651 West Washington Boulevard

•

Suite 400

Chicago, IL 60661

Telephone: 312.651.7350

Indiana

Indiana Chapter

941 East 86th Street

•

Suite 100

Indianapolis, IN 46240

Telephone: 317.726.2270

Iowa

Iowa Chapter

8033 University Boulevard

•

Suite A

Des Moines, IA 50325

Telephone: 515.270.6169 or 800.374.1074

Kansas

Kansas Chapter

555 North Woodlawn

Building 1

•

Suite 113

Wichita, KS 67208

Telephone: 316.687.2222

Mid-America Chapter

6811 West 63rd Street

Cloverleaf Building #1

•

Suite 202

Shawnee Mission, KS 66202-4001

Telephone: 913.262.1515

Kentucky

Kentucky & Southern Indiana Chapter

600 East Main Street

•

Suite 102

Louisville, KY 40202-1077

Telephone: 502.584.8490

Louisiana

Louisiana Chapter

3636 South 1-10 Service Road

•

Suite 304

Metairie, LA 70001

Telephone: 504.837.0945

Maryland

Maryland Chapter

11350 McCormick Road

Executive Plaza lll

•

Suite 100

Hunt Valley, MD 21031

Telephone: 410.527.0220

Massachusetts

Massachusetts Chapter

495 Old Connecticut Path

•

Suite 220

Framingham, MA 01701-4567

Telephone: 508.879.5083 or 800.688.6572

Michigan

Michigan Chapter

1421 East Twelve Mile Road

•

Building A

Madison Heights, MI 48071

Telephone: 248.582.2900

Minnesota

Minnesota Chapter

8441 Wayzata Boulevard

•

Suite 340

Golden Valley, MN 55426

Telephone: 763.545.3309

Mississippi

Mississippi Chapter

405 Fontaine Place

•

Suite 103

Ridgeland, MS 39157

Telephone: 601.956.7447

Missouri

Gateway Chapter

77 West Port Plaza

•

Suite 101

St. Louis, MO 63146-3111

Telephone: 314.878.0780

Nebraska

Nebraska Chapter

10832 Old Mill Road

•

Suite 200

Omaha, NE 68154

Telephone: 402.344.2242

Nevada

Southern Nevada Chapter

6280 South Valley View Boulevard

•

Suite 342

Las Vegas, NV 89118

Telephone: 702.436.4220

New Jersey

Northern New Jersey Chapter

116 South Euclid Avenue

Westﬁeld, NJ 07090

Telephone: 908.654.9445

Southern New Jersey Shore Region Chapter

216 Haddon Avenue

•

Suite 328

Westmont, NJ 08108

Telephone: 856.869.0200

New Mexico

New Mexico/El Paso Chapter

3411 Candelaria NE

•

Suite M

Albuquerque, NM 87107

Telephone: 505.872.0141

New York

Central New York Chapter

Learbury Centre

401 North Salina Street

Syracuse, NY 13203-1770

Telephone: 315.471.1050

Long Island Chapter

555 Broad Hollow Road

Melville, NY 11747

Telephone: 631.752.8500

New York City Chapter

475 Park Avenue South

•

8th Floor

New York, NY 10016

Telephone: 212.448.9206

New York Metro Division

205 Lexington Avenue

•

16th Floor

New York, NY 10016

Telephone: 212.689.1400

Westchester/Hudson Valley Chapter

1311 Mamaroneck Avenue

•

Suite 130

White Plains, NY 10605

Telephone: 914.949.0084

Western New York & Finger Lakes Chapter

4053 Maple Road

Amherst, NY 14226

Telephone: 716.834.2578

Upstate New York/VT Chapter

6 Automation Lane

Albany, NY 12205

Telephone: 518.438.3583

North Carolina

Eastern North Carolina Chapter

4320 Bland Road

•

Flagship Building

Raleigh, NC 27609

Telephone: 919.875.8252

Western North Carolina Chapter

5950 Fairview Road

•

Suite 250

Charlotte, NC 28210

Telephone: 704.998.5012

Ohio

Central Ohio Chapter

2225 City Gate Drive

•

Suite E

Columbus, OH 43219

Telephone: 614.476.7194

Northern Ohio Chapter

902 Westpoint Parkway

•

Suite 300

Cleveland, OH 44145

Telephone: 440.617.2873

Southern Ohio Chapter

2300 Wall Street

•

Suite H

Cincinnati, OH 45212

Telephone: 513.361.2100

Oklahoma

Oklahoma Chapter

500 North Broadway

•

Suite 250

Oklahoma City, OK 73102

Telephone: 405.943.8888

Oregon

Oregon Chapter

9320 SW Barbur Boulevard

•

Suite 140

Portland, OR 97219

Telephone: 503.245.9866

Pennsylvania

Central Pennsylvania Chapter

800 Corporate Circle

•

Suite 100

Harrisburg, PA 17110

Telephone: 717.652.6520

Eastern Pennsylvania Chapter

#2 International Plaza

•

Suite 245

Philadelphia, PA 19113

Telephone: 610.521.8274

Greater Delaware Valley Division

#2 International Plaza

•

Suite 105

Philadelphia, PA 19113

Telephone: 610.521.8274

Western Pennsylvania & West Virginia Chapter

River Walk Corporate Centre

•

Suite 441

333 East Carson Street

Pittsburgh

PA 15219

Telephone: 412.395.2873

Rhode Island

Rhode Island Chpater

1150 Pontiac Avenue

•

Suite 1

Cranston, RI 02920

Telephone: 401.943.8888

South Carolina

South Carolina Chapter

1247 Lake Murray Boulevard

Irmo, SC 29063

Telephone: 803.749.4299

Tennessee

Tennessee Chapter

404 BNA Drive

•

Suite 102

Nashville, TN 37217

Telephone: 615.331.2980

Texas

North Texas Chapter

8111 LBJ Freeway

•

Suite 425

Dallas, TX 75251

Telephone: 972.239.0959

South Texas Chapter

950 Isom Road

•

Suite 104

San Antonio, TX 78216

Telephone: 210.377.1775

Texas Gulf Coast Chapter

5005 Mitchelldale

•

Suite 115

Houston, TX 77092

Telephone: 713.680.8088

Virginia

Virginia Chapter

5511 Staples Mill Road

•

Suite 202B

Richmond, VA 23228

Telephone: 804.627.0400

Washington/Alaska

Washington/Alaska Chapter

530 Dexter Avenue North

•

Suite 300

Seattle, WA 98109

Telephone: 206.628.0777

Washington, D.C.

National Capital Chapter

5845 Richmond Highway

•

Suite 800

Alexandria, VA 22303

Telephone: 703.960.1100

Wisconsin

Wisconsin Chapter

4125 North 124th Street

•

Unit A

Brookﬁeld, WI 53005

Telephone: 262.790.4701

Canadian Ofﬁces

Greater Toronto Area

936 The East Mall

Toronto, ON M9B 6J9

Telephone: 416.661.2873 x107

Western Canada

1682 West 7th Avenue

•

Suite 310

Vancouver, BC V6J 4S6

Telephone: 604.733.2873

2005 | ANNUAL REPORT

chapter offices Alphabetical by state

Photography: Christopher Spielmann

1311 Mamaroneck Avenue

White Plains, New York 10605

Telephone 914.949.5213

Facsimile 914.949.6691

www.LLS.org

The Society is a nonproﬁt

organization that relies on the

generosity of individual and corporate

contributions to advance its mission.

Call our Information Resource Center

toll free at

800.955.4572 or visit www.LLS.org

P001 20M 1/06